ONTOLOGY REPORT - ANNOTATIONS
| Term: | valproic acid |
|
| Accession: | CHEBI:39867
|
browse the term
|
| Definition: | A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem. |
| Synonyms: | related_synonym: | 2-PROPYL-PENTANOIC ACID; 2-n-propyl-n-valeric acid; 2-propylpentanoic acid; 2-propylvaleric acid; 4-heptanecarboxylic acid; C8H16O2; CCCC(CCC)C(O)=O; DPA; Depakene; Di-n-propylessigsaeure; InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10); InChIKey=NIJJYAXOARWZEE-UHFFFAOYSA-N; VPA; Valproinsaeure; acide valproique; acido valproico; acidum valproicum; di-n-propylacetic acid; dipropylacetic acid; n-DPA |
| | alt_id: | CHEBI:115217; CHEBI:39858; CHEBI:9926 |
| | xref_casrn: | 99-66-1 |
| | xref: | ChEMBL:115217 "ChEMBL COMPOUND"; ChemIDplus:1750447 "Beilstein Registry Number"; ChemIDplus:99-66-1 "CAS Registry Number"; CiteXplore:12475192 "PubMed citation"; CiteXplore:17156483 "PubMed citation"; CiteXplore:19280426 "PubMed citation"; CiteXplore:8681902 "PubMed citation"; DrugBank:DB00313 "DrugBank"; KEGG COMPOUND:C07185 "KEGG COMPOUND"; KEGG DRUG:D00399 "KEGG DRUG" |
| | xref_mesh: | MESH:D014635 |
| | xref: | NIST Chemistry WebBook:99-66-1 "CAS Registry Number"; PDBeChem:2PP "PDBeChem"; Wikipedia:Valproic_Acid "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:60654 |
|
|
valproic acid
|
| G |
Abhd17a |
abhydrolase domain containing 17A |
|
affects expression |
EXP |
10 |
80,046,394 |
80,053,086 |
RGD:6480464 |
CTD |
| G |
Abhd17c |
abhydrolase domain containing 17C |
|
affects expression |
EXP |
7 |
91,257,866 |
91,300,403 |
RGD:6480464 |
CTD |
| G |
BC049806 |
cDNA sequence BC049806 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cd63 |
CD63 antigen |
|
increases expression |
ISO |
10 |
128,345,975 |
128,349,878 |
RGD:6480464 |
CTD |
| G |
Cd63 |
CD63 antigen |
|
multiple interactions |
ISO |
10 |
128,345,975 |
128,349,878 |
RGD:6480464 |
CTD |
| G |
Cd80 |
CD80 antigen |
|
affects expression |
EXP |
16 |
38,459,013 |
38,487,015 |
RGD:6480464 |
CTD |
| G |
Cd83 |
CD83 antigen |
|
increases expression |
ISO |
13 |
43,880,476 |
43,898,501 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 antigen |
|
increases expression |
ISO |
6 |
125,410,284 |
125,444,773 |
RGD:6480464 |
CTD |
| G |
Cd96 |
CD96 antigen |
|
affects expression |
EXP |
16 |
46,035,770 |
46,120,361 |
RGD:6480464 |
CTD |
| G |
Cd99 |
CD99 antigen |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdadc1 |
cytidine and dCMP deaminase domain containing 1 |
|
multiple interactions |
ISO |
14 |
60,178,225 |
60,216,796 |
RGD:6480464 |
CTD |
| G |
Cdc14b |
CDC14 cell division cycle 14B |
|
affects expression |
EXP |
13 |
64,293,853 |
64,376,296 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
affects expression |
EXP |
4 |
118,105,506 |
118,109,948 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
affects expression |
EXP |
9 |
109,778,083 |
109,796,394 |
RGD:6480464 |
CTD |
| G |
Cdc26 |
cell division cycle 26 |
|
affects expression |
EXP |
4 |
62,055,623 |
62,069,657 |
RGD:6480464 |
CTD |
| G |
Cdc27 |
cell division cycle 27 |
|
decreases expression |
EXP |
11 |
104,363,838 |
104,411,934 |
RGD:6480464 |
CTD |
| G |
Cdc37 |
cell division cycle 37 |
|
multiple interactions |
ISO |
9 |
20,942,985 |
20,954,350 |
RGD:6480464 |
CTD |
| G |
Cdc40 |
cell division cycle 40 |
|
affects expression |
EXP |
10 |
40,552,699 |
40,602,949 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 |
|
multiple interactions |
ISO |
4 |
136,875,611 |
136,913,652 |
RGD:6480464 |
CTD |
| G |
Cdc42ep2 |
CDC42 effector protein (Rho GTPase binding) 2 |
|
increases expression |
EXP |
19 |
5,917,561 |
5,918,995 |
RGD:6480464 |
CTD |
| G |
Cdc42ep3 |
CDC42 effector protein (Rho GTPase binding) 3 |
|
affects expression |
EXP |
17 |
79,733,365 |
79,754,431 |
RGD:6480464 |
CTD |
| G |
Cdc42ep4 |
CDC42 effector protein (Rho GTPase binding) 4 |
|
affects expression |
EXP |
11 |
113,588,164 |
113,613,129 |
RGD:6480464 |
CTD |
| G |
Cdc42ep5 |
CDC42 effector protein (Rho GTPase binding) 5 |
|
increases expression |
ISO |
7 |
4,102,862 |
4,116,304 |
RGD:6480464 |
CTD |
| G |
Cdc42ep5 |
CDC42 effector protein (Rho GTPase binding) 5 |
|
affects expression |
EXP |
7 |
4,102,862 |
4,116,304 |
RGD:6480464 |
CTD |
| G |
Cdc42se1 |
CDC42 small effector 1 |
|
affects expression |
EXP |
3 |
95,032,702 |
95,040,331 |
RGD:6480464 |
CTD |
| G |
Cdc42se1 |
CDC42 small effector 1 |
|
decreases expression |
EXP |
3 |
95,032,702 |
95,040,331 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
affects expression |
EXP |
11 |
98,769,203 |
98,785,256 |
RGD:6480464 |
CTD |
| G |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
|
affects expression |
EXP |
1 |
145,454,629 |
145,549,814 |
RGD:6480464 |
CTD |
| G |
Cdca4 |
cell division cycle associated 4 |
|
affects expression |
EXP |
12 |
114,058,445 |
114,067,600 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
decreases expression |
ISO |
19 |
6,085,097 |
6,091,773 |
RGD:6480464 |
CTD |
| G |
Cdca5 |
cell division cycle associated 5 |
|
decreases expression |
EXP |
19 |
6,085,097 |
6,091,773 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
affects expression |
EXP |
2 |
72,314,276 |
72,324,947 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
decreases expression |
EXP |
2 |
72,314,276 |
72,324,947 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
affects expression |
EXP |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
increases expression |
EXP |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
increases expression |
ISO |
8 |
105,156,895 |
105,309,011 |
RGD:6480464 |
CTD |
| G |
Cdk12 |
cyclin-dependent kinase 12 |
|
multiple interactions |
ISO |
11 |
98,064,619 |
98,114,854 |
RGD:6480464 |
CTD |
| G |
Cdk12 |
cyclin-dependent kinase 12 |
|
affects expression |
EXP |
11 |
98,064,619 |
98,114,854 |
RGD:6480464 |
CTD |
| G |
Chmp3 |
charged multivesicular body protein 3 |
|
decreases expression |
EXP |
6 |
71,493,848 |
71,531,568 |
RGD:6480464 |
CTD |
| G |
Chmp4c |
charged multivesicular body protein 4C |
|
affects expression |
EXP |
3 |
10,366,973 |
10,391,005 |
RGD:6480464 |
CTD |
| G |
Chmp5 |
charged multivesicular body protein 5 |
|
multiple interactions |
ISO |
4 |
40,895,586 |
40,912,335 |
RGD:6480464 |
CTD |
| G |
Chn2 |
chimerin (chimaerin) 2 |
|
multiple interactions |
ISO |
6 |
53,989,926 |
54,251,806 |
RGD:6480464 |
CTD |
| G |
Chn2 |
chimerin (chimaerin) 2 |
|
affects expression |
EXP |
6 |
53,989,926 |
54,251,806 |
RGD:6480464 |
CTD |
| G |
Chodl |
chondrolectin |
|
affects expression |
EXP |
16 |
78,931,193 |
78,951,973 |
RGD:6480464 |
CTD |
| G |
Chordc1 |
cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein 1 |
|
affects expression |
EXP |
9 |
18,096,711 |
18,118,444 |
RGD:6480464 |
CTD |
| G |
Chpt1 |
choline phosphotransferase 1 |
|
increases expression |
ISO |
10 |
87,935,558 |
87,966,715 |
RGD:6480464 |
CTD |
| G |
Chpt1 |
choline phosphotransferase 1 |
|
affects expression |
EXP |
10 |
87,935,558 |
87,966,715 |
RGD:6480464 |
CTD |
| G |
Chrd |
chordin |
|
affects expression |
EXP |
16 |
20,733,200 |
20,742,457 |
RGD:6480464 |
CTD |
| G |
Chrna1 |
cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) |
|
multiple interactions |
ISO |
2 |
73,401,338 |
73,418,363 |
RGD:6480464 |
CTD |
| G |
Chrna10 |
cholinergic receptor, nicotinic, alpha polypeptide 10 |
|
affects expression |
EXP |
7 |
109,259,780 |
109,265,227 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha polypeptide 4 |
|
affects expression |
EXP |
2 |
180,757,016 |
180,773,882 |
RGD:6480464 |
CTD |
| G |
Chrna9 |
cholinergic receptor, nicotinic, alpha polypeptide 9 |
|
affects expression |
EXP |
5 |
66,358,363 |
66,368,725 |
RGD:6480464 |
CTD |
| G |
Chrnb4 |
cholinergic receptor, nicotinic, beta polypeptide 4 |
|
increases expression |
EXP |
9 |
54,875,963 |
54,896,351 |
RGD:6480464 |
CTD |
| G |
Chst1 |
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
|
increases expression |
ISO |
2 |
92,439,864 |
92,455,409 |
RGD:6480464 |
CTD |
| G |
Chst13 |
carbohydrate (chondroitin 4) sulfotransferase 13 |
|
multiple interactions |
ISO |
6 |
90,258,345 |
90,275,179 |
RGD:6480464 |
CTD |
| G |
Chst15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
|
increases expression |
ISO |
7 |
139,427,938 |
139,508,838 |
RGD:6480464 |
CTD |
| G |
Ciao1 |
cytosolic iron-sulfur protein assembly 1 |
|
affects expression |
EXP |
2 |
127,066,674 |
127,073,552 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
multiple interactions |
ISO |
7 |
87,372,046 |
87,377,502 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
affects expression |
EXP |
7 |
87,372,046 |
87,377,502 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
increases expression |
ISO |
7 |
87,372,046 |
87,377,502 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
increases expression |
EXP |
7 |
87,372,046 |
87,377,502 |
RGD:6480464 |
CTD |
| G |
Cib2 |
calcium and integrin binding family member 2 |
|
affects expression |
EXP |
9 |
54,393,159 |
54,407,886 |
RGD:6480464 |
CTD |
| G |
Cib2 |
calcium and integrin binding family member 2 |
|
increases expression |
EXP |
9 |
54,393,159 |
54,407,886 |
RGD:6480464 |
CTD |
| G |
Cic |
capicua homolog (Drosophila) |
|
affects expression |
EXP |
7 |
26,067,198 |
26,079,167 |
RGD:6480464 |
CTD |
| G |
Cirh1a |
cirrhosis, autosomal recessive 1A (human) |
|
affects expression |
EXP |
8 |
109,417,540 |
109,446,994 |
RGD:6480464 |
CTD |
| G |
Cisd1 |
CDGSH iron sulfur domain 1 |
|
affects expression |
EXP |
10 |
70,793,242 |
70,807,597 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression |
EXP |
10 |
17,443,034 |
17,445,480 |
RGD:6480464 |
CTD |
| G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
affects expression |
EXP |
4 |
120,339,168 |
120,340,425 |
RGD:6480464 |
CTD |
| G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
increases expression |
EXP |
4 |
120,339,168 |
120,340,425 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
12 |
112,907,566 |
112,910,549 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
affects expression |
EXP |
12 |
112,907,566 |
112,910,549 |
RGD:6480464 |
CTD |
| G |
Cklf |
chemokine-like factor |
|
increases expression |
EXP |
8 |
106,774,803 |
106,788,836 |
RGD:6480464 |
CTD |
| G |
Ckmt1 |
creatine kinase, mitochondrial 1, ubiquitous |
|
affects expression |
EXP |
2 |
121,184,377 |
121,189,473 |
RGD:6480464 |
CTD |
| G |
Clasp2 |
CLIP associating protein 2 |
|
multiple interactions |
ISO |
9 |
113,650,591 |
113,828,815 |
RGD:6480464 |
CTD |
| G |
Clcc1 |
chloride channel CLIC-like 1 |
|
affects expression |
EXP |
3 |
108,456,831 |
108,481,758 |
RGD:6480464 |
CTD |
| G |
Clcn5 |
chloride channel 5 |
|
multiple interactions |
ISO |
X |
6,735,945 |
6,765,840 |
RGD:6480464 |
CTD |
| G |
Clcnkb |
chloride channel Kb |
|
affects expression |
EXP |
4 |
140,960,272 |
140,971,903 |
RGD:6480464 |
CTD |
| G |
Cldn14 |
claudin 14 |
|
affects expression |
EXP |
16 |
93,919,276 |
94,009,082 |
RGD:6480464 |
CTD |
| G |
Cldn16 |
claudin 16 |
|
affects expression |
EXP |
16 |
26,463,246 |
26,482,853 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
affects expression |
EXP |
X |
136,335,367 |
136,345,923 |
RGD:6480464 |
CTD |
| G |
Cldnd2 |
claudin domain containing 2 |
|
affects expression |
EXP |
7 |
50,696,186 |
50,698,690 |
RGD:6480464 |
CTD |
| G |
Clec16a |
C-type lectin domain family 16, member A |
|
affects expression |
EXP |
16 |
10,545,480 |
10,744,964 |
RGD:6480464 |
CTD |
| G |
Clec1a |
C-type lectin domain family 1, member a |
|
affects expression |
EXP |
6 |
129,376,702 |
129,402,018 |
RGD:6480464 |
CTD |
| G |
Clec4b1 |
C-type lectin domain family 4, member b1 |
|
affects expression |
EXP |
6 |
122,999,980 |
123,021,573 |
RGD:6480464 |
CTD |
| G |
Clec4e |
C-type lectin domain family 4, member e |
|
affects expression |
EXP |
6 |
123,231,807 |
123,239,889 |
RGD:6480464 |
CTD |
| G |
Clic1 |
chloride intracellular channel 1 |
|
affects expression |
EXP |
17 |
35,187,188 |
35,195,664 |
RGD:6480464 |
CTD |
| G |
Clic6 |
chloride intracellular channel 6 |
|
increases expression |
EXP |
16 |
92,498,392 |
92,541,486 |
RGD:6480464 |
CTD |
| G |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
|
affects expression |
EXP |
17 |
72,119,031 |
72,207,691 |
RGD:6480464 |
CTD |
| G |
Clk1 |
CDC-like kinase 1 |
|
affects expression |
EXP |
1 |
58,468,832 |
58,480,932 |
RGD:6480464 |
CTD |
| G |
Clk4 |
CDC like kinase 4 |
|
decreases expression |
EXP |
11 |
51,076,673 |
51,095,266 |
RGD:6480464 |
CTD |
| G |
Clmn |
calmin |
|
increases expression |
ISO |
12 |
106,001,324 |
106,103,286 |
RGD:6480464 |
CTD |
| G |
Clmp |
CXADR-like membrane protein |
|
decreases expression |
ISO |
9 |
40,494,047 |
40,592,129 |
RGD:6480464 |
CTD |
| G |
Cln8 |
ceroid-lipofuscinosis, neuronal 8 |
|
increases expression |
ISO |
8 |
14,888,536 |
14,901,720 |
RGD:6480464 |
CTD |
| G |
Clpx |
caseinolytic peptidase X (E.coli) |
|
affects expression |
EXP |
9 |
65,142,102 |
65,178,465 |
RGD:6480464 |
CTD |
| G |
Cltb |
clathrin, light polypeptide (Lcb) |
|
affects expression |
EXP |
13 |
54,694,300 |
54,712,633 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
multiple interactions |
ISO |
14 |
122,580,916 |
122,801,456 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
increases expression |
ISO |
14 |
122,580,916 |
122,801,456 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
affects expression |
EXP |
14 |
122,580,916 |
122,801,456 |
RGD:6480464 |
CTD |
| G |
Cml1 |
camello-like 1 |
|
affects expression |
EXP |
6 |
85,860,148 |
85,865,671 |
RGD:6480464 |
CTD |
| G |
Cml2 |
camello-like 2 |
|
affects expression |
EXP |
6 |
85,815,416 |
85,819,131 |
RGD:6480464 |
CTD |
| G |
Cml3 |
camello-like 3 |
|
affects expression |
EXP |
6 |
85,710,625 |
85,715,738 |
RGD:6480464 |
CTD |
| G |
Cmtm8 |
CKLF-like MARVEL transmembrane domain containing 8 |
|
affects expression |
EXP |
9 |
114,698,463 |
114,753,270 |
RGD:6480464 |
CTD |
| G |
Cngb1 |
cyclic nucleotide gated channel beta 1 |
|
affects expression |
EXP |
8 |
97,814,493 |
97,830,485 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases expression |
EXP |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb3 |
cAMP responsive element binding protein 3 |
|
affects expression |
EXP |
4 |
43,575,506 |
43,579,932 |
RGD:6480464 |
CTD |
| G |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
|
increases expression |
EXP |
2 |
91,822,485 |
91,864,327 |
RGD:6480464 |
CTD |
| G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
|
affects expression |
EXP |
10 |
80,547,078 |
80,561,617 |
RGD:6480464 |
CTD |
| G |
Creb3l4 |
cAMP responsive element binding protein 3-like 4 |
|
affects expression |
EXP |
3 |
90,041,422 |
90,047,434 |
RGD:6480464 |
CTD |
| G |
Creb3l4 |
cAMP responsive element binding protein 3-like 4 |
|
increases expression |
EXP |
3 |
90,041,422 |
90,047,434 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
decreases expression |
ISO |
16 |
4,084,048 |
4,213,404 |
RGD:6480464 |
CTD |
| G |
Crebzf |
CREB/ATF bZIP transcription factor |
|
decreases expression |
EXP |
7 |
97,591,291 |
97,596,231 |
RGD:6480464 |
CTD |
| G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
|
increases expression |
ISO |
1 |
167,693,911 |
167,705,435 |
RGD:6480464 |
CTD |
| G |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
|
increases expression |
EXP |
1 |
167,693,911 |
167,705,435 |
RGD:6480464 |
CTD |
| G |
Creld1 |
cysteine-rich with EGF-like domains 1 |
|
affects expression |
EXP |
6 |
113,433,563 |
113,443,332 |
RGD:6480464 |
CTD |
| G |
Creld2 |
cysteine-rich with EGF-like domains 2 |
|
affects expression |
EXP |
15 |
88,650,076 |
88,657,111 |
RGD:6480464 |
CTD |
| G |
Crip1 |
cysteine-rich protein 1 (intestinal) |
|
increases expression |
EXP |
12 |
114,390,223 |
114,392,090 |
RGD:6480464 |
CTD |
| G |
Crip2 |
cysteine rich protein 2 |
|
affects expression |
EXP |
12 |
114,378,447 |
114,383,717 |
RGD:6480464 |
CTD |
| G |
Cript |
cysteine-rich PDZ-binding protein |
|
affects expression |
EXP |
17 |
87,424,901 |
87,435,148 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
affects expression |
EXP |
16 |
17,452,080 |
17,486,348 |
RGD:6480464 |
CTD |
| G |
Crlf1 |
cytokine receptor-like factor 1 |
|
affects expression |
EXP |
8 |
73,017,055 |
73,027,980 |
RGD:6480464 |
CTD |
| G |
Crmp1 |
collapsin response mediator protein 1 |
|
affects expression |
EXP |
5 |
37,633,319 |
37,683,372 |
RGD:6480464 |
CTD |
| G |
Crnkl1 |
Crn, crooked neck-like 1 (Drosophila) |
|
affects expression |
EXP |
2 |
145,743,218 |
145,760,436 |
RGD:6480464 |
CTD |
| G |
Crocc |
ciliary rootlet coiled-coil, rootletin |
|
affects expression |
EXP |
4 |
140,572,552 |
140,616,460 |
RGD:6480464 |
CTD |
| G |
Crot |
carnitine O-octanoyltransferase |
|
affects expression |
EXP |
5 |
8,966,048 |
8,997,146 |
RGD:6480464 |
CTD |
| G |
Crtc3 |
CREB regulated transcription coactivator 3 |
|
affects expression |
EXP |
7 |
87,731,518 |
87,833,763 |
RGD:6480464 |
CTD |
| G |
Cryaa |
crystallin, alpha A |
|
affects expression |
EXP |
17 |
31,814,890 |
31,818,669 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
decreases expression |
EXP |
9 |
50,560,863 |
50,564,738 |
RGD:6480464 |
CTD |
| G |
Cryba2 |
crystallin, beta A2 |
|
affects expression |
EXP |
1 |
74,936,518 |
74,939,709 |
RGD:6480464 |
CTD |
| G |
Cryba4 |
crystallin, beta A4 |
|
multiple interactions |
ISO |
5 |
112,675,553 |
112,681,522 |
RGD:6480464 |
CTD |
| G |
Crygs |
crystallin, gamma S |
|
affects expression |
EXP |
16 |
22,805,276 |
22,811,483 |
RGD:6480464 |
CTD |
| G |
Cryl1 |
crystallin, lambda 1 |
|
affects expression |
EXP |
14 |
57,893,871 |
58,017,320 |
RGD:6480464 |
CTD |
| G |
Cryz |
crystallin, zeta |
|
increases expression |
ISO |
3 |
154,259,976 |
154,286,146 |
RGD:6480464 |
CTD |
| G |
Csad |
cysteine sulfinic acid decarboxylase |
|
affects expression |
EXP |
15 |
102,007,429 |
102,019,474 |
RGD:6480464 |
CTD |
| G |
Cse1l |
chromosome segregation 1-like (S. cerevisiae) |
|
affects expression |
EXP |
2 |
166,731,596 |
166,771,889 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
affects expression |
EXP |
11 |
98,562,627 |
98,564,943 |
RGD:6480464 |
CTD |
| G |
Csf3r |
colony stimulating factor 3 receptor (granulocyte) |
|
affects expression |
EXP |
4 |
125,701,903 |
125,721,684 |
RGD:6480464 |
CTD |
| G |
Csmd2 |
CUB and Sushi multiple domains 2 |
|
affects expression |
EXP |
4 |
127,665,294 |
128,245,100 |
RGD:6480464 |
CTD |
| G |
Csnk1d |
casein kinase 1, delta |
|
affects expression |
EXP |
11 |
120,823,055 |
120,852,647 |
RGD:6480464 |
CTD |
| G |
Csnk1d |
casein kinase 1, delta |
|
decreases expression |
EXP |
11 |
120,823,055 |
120,852,647 |
RGD:6480464 |
CTD |
| G |
Csnk1g2 |
casein kinase 1, gamma 2 |
|
affects expression |
EXP |
10 |
80,085,525 |
80,103,516 |
RGD:6480464 |
CTD |
| G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
|
decreases expression |
EXP |
2 |
152,052,576 |
152,107,588 |
RGD:6480464 |
CTD |
| G |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
|
affects expression |
EXP |
16 |
64,477,636 |
64,478,960 |
RGD:6480464 |
CTD |
| G |
Csrnp2 |
cysteine-serine-rich nuclear protein 2 |
|
increases expression |
EXP |
15 |
100,310,001 |
100,325,670 |
RGD:6480464 |
CTD |
| G |
Cst10 |
cystatin 10 (chondrocytes) |
|
affects expression |
EXP |
2 |
149,230,985 |
149,236,014 |
RGD:6480464 |
CTD |
| G |
Cst8 |
cystatin 8 (cystatin-related epididymal spermatogenic) |
|
affects expression |
EXP |
2 |
148,624,575 |
148,631,320 |
RGD:6480464 |
CTD |
| G |
Cstf1 |
cleavage stimulation factor, 3' pre-RNA, subunit 1 |
|
decreases expression |
EXP |
2 |
172,196,503 |
172,206,586 |
RGD:6480464 |
CTD |
| G |
Cstf2 |
cleavage stimulation factor, 3' pre-RNA subunit 2 |
|
decreases expression |
EXP |
X |
130,593,888 |
130,621,360 |
RGD:6480464 |
CTD |
| G |
Cstf3 |
cleavage stimulation factor, 3' pre-RNA, subunit 3 |
|
affects expression |
EXP |
2 |
104,430,641 |
104,505,582 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor |
|
multiple interactions |
ISO |
8 |
108,160,438 |
108,206,822 |
RGD:6480464 |
CTD |
| G |
Ctcf |
CCCTC-binding factor |
|
decreases expression |
EXP |
8 |
108,160,438 |
108,206,822 |
RGD:6480464 |
CTD |
| G |
Ctdsp2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
|
affects expression |
EXP |
10 |
126,415,773 |
126,437,031 |
RGD:6480464 |
CTD |
| G |
Ctgf |
connective tissue growth factor |
|
affects expression |
EXP |
10 |
24,315,248 |
24,318,489 |
RGD:6480464 |
CTD |
| G |
Cthrc1 |
collagen triple helix repeat containing 1 |
|
increases expression |
ISO |
15 |
38,908,478 |
38,918,665 |
RGD:6480464 |
CTD |
| G |
Cthrc1 |
collagen triple helix repeat containing 1 |
|
increases expression |
EXP |
15 |
38,908,478 |
38,918,665 |
RGD:6480464 |
CTD |
| G |
Ctif |
CBP80/20-dependent translation initiation factor |
|
affects expression |
EXP |
18 |
75,590,859 |
75,857,350 |
RGD:6480464 |
CTD |
| G |
Ctif |
CBP80/20-dependent translation initiation factor |
|
increases expression |
EXP |
18 |
75,590,859 |
75,857,350 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
9 |
120,842,518 |
120,869,625 |
RGD:6480464 |
CTD |
| G |
Ctnnbip1 |
catenin beta interacting protein 1 |
|
decreases expression |
EXP |
4 |
148,892,350 |
148,940,546 |
RGD:6480464 |
CTD |
| G |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
|
multiple interactions |
ISO |
2 |
84,440,938 |
84,490,897 |
RGD:6480464 |
CTD |
| G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
|
affects expression |
EXP |
3 |
130,993,409 |
131,006,145 |
RGD:6480464 |
CTD |
| G |
Cyp39a1 |
cytochrome P450, family 39, subfamily a, polypeptide 1 |
|
affects expression |
EXP |
17 |
43,804,374 |
43,888,380 |
RGD:6480464 |
CTD |
| G |
Cyp46a1 |
cytochrome P450, family 46, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
12 |
109,572,591 |
109,600,444 |
RGD:6480464 |
CTD |
| G |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
|
decreases expression |
ISO |
4 |
115,190,892 |
115,206,254 |
RGD:6480464 |
CTD |
| G |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
|
increases expression |
ISO |
4 |
115,190,892 |
115,206,254 |
RGD:6480464 |
CTD |
| G |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
|
affects expression |
EXP |
4 |
115,190,892 |
115,206,254 |
RGD:6480464 |
CTD |
| G |
Cyp4a12b |
cytochrome P450, family 4, subfamily a, polypeptide 12B |
|
increases expression |
ISO |
4 |
115,084,229 |
115,111,639 |
RGD:6480464 |
CTD |
| G |
Cyp4a14 |
cytochrome P450, family 4, subfamily a, polypeptide 14 |
|
affects expression |
EXP |
4 |
115,158,805 |
115,168,746 |
RGD:6480464 |
CTD |
| G |
Cyp4a14 |
cytochrome P450, family 4, subfamily a, polypeptide 14 |
|
decreases expression |
EXP |
4 |
115,158,805 |
115,168,746 |
RGD:6480464 |
CTD |
| G |
Cyp4a31 |
cytochrome P450, family 4, subfamily a, polypeptide 31 |
|
affects expression |
EXP |
4 |
115,236,322 |
115,251,619 |
RGD:6480464 |
CTD |
| G |
Cyp4a31 |
cytochrome P450, family 4, subfamily a, polypeptide 31 |
|
decreases expression |
EXP |
4 |
115,236,322 |
115,251,619 |
RGD:6480464 |
CTD |
| G |
Cyp4x1 |
cytochrome P450, family 4, subfamily x, polypeptide 1 |
|
multiple interactions |
ISO |
4 |
114,781,287 |
114,806,582 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
affects expression |
EXP |
5 |
4,080,674 |
4,104,697 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine rich protein 61 |
|
affects expression |
EXP |
3 |
145,309,935 |
145,312,949 |
RGD:6480464 |
CTD |
| G |
Cys1 |
cystin 1 |
|
affects expression |
EXP |
12 |
25,350,703 |
25,366,660 |
RGD:6480464 |
CTD |
| G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
decreases expression |
EXP |
X |
103,771,856 |
103,798,801 |
RGD:6480464 |
CTD |
| G |
Cystm1 |
cysteine-rich transmembrane module containing 1 |
|
increases expression |
ISO |
18 |
36,508,278 |
36,553,024 |
RGD:6480464 |
CTD |
| G |
D10Wsu102e |
DNA segment, Chr 10, Wayne State University 102, expressed |
|
affects expression |
EXP |
10 |
82,822,966 |
82,831,580 |
RGD:6480464 |
CTD |
| G |
D15Mgi27 |
DNA Segment, Chr 15, Mouse Genome Informatics 27 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
D17H6S56E-5 |
DNA segment, Chr 17, human D6S56E 5 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
D19Bwg1357e |
DNA segment, Chr 19, Brigham & Women's Genetics 1357 expressed |
|
affects expression |
EXP |
19 |
27,463,192 |
27,504,310 |
RGD:6480464 |
CTD |
| G |
D19Bwg1357e |
DNA segment, Chr 19, Brigham & Women's Genetics 1357 expressed |
|
decreases expression |
EXP |
19 |
27,463,192 |
27,504,310 |
RGD:6480464 |
CTD |
| G |
D1Ertd622e |
DNA segment, Chr 1, ERATO Doi 622, expressed |
|
affects expression |
EXP |
1 |
99,540,479 |
99,558,595 |
RGD:6480464 |
CTD |
| G |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
|
affects expression |
EXP |
6 |
143,194,408 |
143,246,399 |
RGD:6480464 |
CTD |
| G |
D6Wsu163e |
DNA segment, Chr 6, Wayne State University 163, expressed |
|
affects expression |
EXP |
6 |
126,889,984 |
126,925,722 |
RGD:6480464 |
CTD |
| G |
Daam1 |
dishevelled associated activator of morphogenesis 1 |
|
increases expression |
ISO |
12 |
72,932,065 |
73,093,354 |
RGD:6480464 |
CTD |
| G |
Dab1 |
disabled 1 |
|
decreases expression |
ISO |
4 |
103,291,964 |
103,851,531 |
RGD:6480464 |
CTD |
| G |
Dab1 |
disabled 1 |
|
affects expression |
EXP |
4 |
103,291,964 |
103,851,531 |
RGD:6480464 |
CTD |
| G |
Dab1 |
disabled 1 |
|
increases expression |
ISO |
4 |
103,291,964 |
103,851,531 |
RGD:6480464 |
CTD |
| G |
Dab2ip |
disabled 2 interacting protein |
|
affects expression |
EXP |
2 |
35,413,978 |
35,586,514 |
RGD:6480464 |
CTD |
| G |
Dact2 |
dapper homolog 2, antagonist of beta-catenin (xenopus) |
|
affects expression |
EXP |
17 |
14,332,237 |
14,340,838 |
RGD:6480464 |
CTD |
| G |
Dact2 |
dapper homolog 2, antagonist of beta-catenin (xenopus) |
|
multiple interactions |
ISO |
17 |
14,332,237 |
14,340,838 |
RGD:6480464 |
CTD |
| G |
Dact3 |
dapper homolog 3, antagonist of beta-catenin (xenopus) |
|
increases expression |
ISO |
7 |
17,460,666 |
17,472,650 |
RGD:6480464 |
CTD |
| G |
Dagla |
diacylglycerol lipase, alpha |
|
affects expression |
EXP |
19 |
10,319,755 |
10,379,367 |
RGD:6480464 |
CTD |
| G |
Dak |
dihydroxyacetone kinase 2 homolog (yeast) |
|
affects expression |
EXP |
19 |
10,666,687 |
10,678,748 |
RGD:6480464 |
CTD |
| G |
Dalrd3 |
DALR anticodon binding domain containing 3 |
|
increases expression |
EXP |
9 |
108,472,223 |
108,475,102 |
RGD:6480464 |
CTD |
| G |
Dancr |
differentiation antagonizing non-protein coding RNA |
|
multiple interactions |
ISO |
5 |
74,489,108 |
74,490,361 |
RGD:6480464 |
CTD |
| G |
Dap |
death-associated protein |
|
increases expression |
EXP |
15 |
31,154,140 |
31,204,093 |
RGD:6480464 |
CTD |
| G |
Dap3 |
death associated protein 3 |
|
increases expression |
EXP |
3 |
88,724,725 |
88,754,204 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
affects expression |
EXP |
13 |
60,703,308 |
60,864,547 |
RGD:6480464 |
CTD |
| G |
Dapk2 |
death-associated protein kinase 2 |
|
increases expression |
EXP |
9 |
66,006,033 |
66,120,049 |
RGD:6480464 |
CTD |
| G |
Dapk3 |
death-associated protein kinase 3 |
|
affects expression |
EXP |
10 |
80,645,752 |
80,655,942 |
RGD:6480464 |
CTD |
| G |
Dazap1 |
DAZ associated protein 1 |
|
affects expression |
EXP |
10 |
79,727,736 |
79,751,158 |
RGD:6480464 |
CTD |
| G |
Dazap1 |
DAZ associated protein 1 |
|
decreases expression |
EXP |
10 |
79,727,736 |
79,751,158 |
RGD:6480464 |
CTD |
| G |
Dazap1 |
DAZ associated protein 1 |
|
increases expression |
EXP |
10 |
79,727,736 |
79,751,158 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor |
|
multiple interactions |
ISO |
1 |
122,009,857 |
122,017,673 |
RGD:6480464 |
CTD |
| G |
Dbi |
diazepam binding inhibitor |
|
affects expression |
EXP |
1 |
122,009,857 |
122,017,673 |
RGD:6480464 |
CTD |
| G |
Dbp |
D site albumin promoter binding protein |
|
affects expression |
EXP |
7 |
52,960,617 |
52,965,573 |
RGD:6480464 |
CTD |
| G |
Dcaf12 |
DDB1 and CUL4 associated factor 12 |
|
affects expression |
EXP |
4 |
41,238,333 |
41,261,934 |
RGD:6480464 |
CTD |
| G |
Dcaf12l1 |
DDB1 and CUL4 associated factor 12-like 1 |
|
affects expression |
EXP |
X |
42,139,749 |
42,143,328 |
RGD:6480464 |
CTD |
| G |
Dcaf13 |
DDB1 and CUL4 associated factor 13 |
|
affects expression |
EXP |
15 |
38,944,420 |
38,978,402 |
RGD:6480464 |
CTD |
| G |
Dcaf15 |
DDB1 and CUL4 associated factor 15 |
|
affects expression |
EXP |
8 |
86,620,971 |
86,628,661 |
RGD:6480464 |
CTD |
| G |
Dcaf5 |
DDB1 and CUL4 associated factor 5 |
|
increases expression |
ISO |
12 |
81,436,834 |
81,537,588 |
RGD:6480464 |
CTD |
| G |
Dcaf6 |
DDB1 and CUL4 associated factor 6 |
|
increases expression |
ISO |
1 |
167,259,631 |
167,390,594 |
RGD:6480464 |
CTD |
| G |
Dcaf7 |
DDB1 and CUL4 associated factor 7 |
|
affects expression |
EXP |
11 |
105,898,186 |
105,920,638 |
RGD:6480464 |
CTD |
| G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
|
multiple interactions |
ISO |
1 |
174,078,146 |
174,126,524 |
RGD:6480464 |
CTD |
| G |
Dcbld1 |
discoidin, CUB and LCCL domain containing 1 |
|
affects expression |
EXP |
10 |
51,953,425 |
52,041,183 |
RGD:6480464 |
CTD |
| G |
Dclk2 |
doublecortin-like kinase 2 |
|
affects expression |
EXP |
3 |
86,590,073 |
86,724,803 |
RGD:6480464 |
CTD |
| G |
Dclre1c |
DNA cross-link repair 1C, PSO2 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
2 |
3,341,403 |
3,378,385 |
RGD:6480464 |
CTD |
| G |
Dennd6a |
DENN/MADD domain containing 6A |
|
affects expression |
EXP |
14 |
27,399,036 |
27,451,586 |
RGD:6480464 |
CTD |
| G |
Dis3l |
DIS3 mitotic control homolog (S. cerevisiae)-like |
|
affects expression |
EXP |
9 |
64,154,563 |
64,189,064 |
RGD:6480464 |
CTD |
| G |
Dixdc1 |
DIX domain containing 1 |
|
affects expression |
EXP |
9 |
50,470,857 |
50,536,089 |
RGD:6480464 |
CTD |
| G |
Dkc1 |
dyskeratosis congenita 1, dyskerin |
|
decreases expression |
ISO |
X |
72,341,193 |
72,355,115 |
RGD:6480464 |
CTD |
| G |
Dkk3 |
dickkopf homolog 3 (Xenopus laevis) |
|
affects expression |
EXP |
7 |
119,259,533 |
119,302,571 |
RGD:6480464 |
CTD |
| G |
Dkk3 |
dickkopf homolog 3 (Xenopus laevis) |
|
increases expression |
ISO |
7 |
119,259,533 |
119,302,571 |
RGD:6480464 |
CTD |
| G |
Dkkl1 |
dickkopf-like 1 |
|
increases expression |
EXP |
7 |
52,462,895 |
52,467,253 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) |
|
multiple interactions |
ISO |
9 |
50,442,738 |
50,467,885 |
RGD:6480464 |
CTD |
| G |
Dlat |
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex) |
|
affects expression |
EXP |
9 |
50,442,738 |
50,467,885 |
RGD:6480464 |
CTD |
| G |
Dlc1 |
deleted in liver cancer 1 |
|
affects expression |
EXP |
8 |
37,630,799 |
37,676,928 |
RGD:6480464 |
CTD |
| G |
Dlc1 |
deleted in liver cancer 1 |
|
decreases expression |
EXP |
8 |
37,630,799 |
37,676,928 |
RGD:6480464 |
CTD |
| G |
Dleu7 |
deleted in lymphocytic leukemia, 7 |
|
decreases expression |
EXP |
14 |
62,895,066 |
62,911,816 |
RGD:6480464 |
CTD |
| G |
Dlg2 |
discs, large homolog 2 (Drosophila) |
|
affects expression |
EXP |
7 |
98,239,296 |
99,597,599 |
RGD:6480464 |
CTD |
| G |
Dlg5 |
discs, large homolog 5 (Drosophila) |
|
increases expression |
EXP |
14 |
24,953,175 |
25,065,142 |
RGD:6480464 |
CTD |
| G |
Dlg5 |
discs, large homolog 5 (Drosophila) |
|
decreases expression |
EXP |
14 |
24,953,175 |
25,065,142 |
RGD:6480464 |
CTD |
| G |
Dlk2 |
delta-like 2 homolog (Drosophila) |
|
affects expression |
EXP |
17 |
46,434,370 |
46,440,220 |
RGD:6480464 |
CTD |
| G |
Dll4 |
delta-like 4 (Drosophila) |
|
affects expression |
EXP |
2 |
119,151,520 |
119,161,402 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
affects expression |
EXP |
12 |
86,451,783 |
86,475,041 |
RGD:6480464 |
CTD |
| G |
Dlst |
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
|
multiple interactions |
ISO |
12 |
86,451,783 |
86,475,041 |
RGD:6480464 |
CTD |
| G |
Dlx2 |
distal-less homeobox 2 |
|
increases expression |
ISO |
2 |
71,381,465 |
71,384,811 |
RGD:6480464 |
CTD |
| G |
Dmbx1 |
diencephalon/mesencephalon homeobox 1 |
|
affects expression |
EXP |
4 |
115,587,724 |
115,612,531 |
RGD:6480464 |
CTD |
| G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
|
affects expression |
EXP |
19 |
25,580,196 |
25,678,818 |
RGD:6480464 |
CTD |
| G |
Dmrt2 |
doublesex and mab-3 related transcription factor 2 |
|
affects expression |
EXP |
19 |
25,746,901 |
25,753,481 |
RGD:6480464 |
CTD |
| G |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
|
decreases expression |
EXP |
4 |
109,650,630 |
109,656,289 |
RGD:6480464 |
CTD |
| G |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
|
increases expression |
EXP |
4 |
109,650,630 |
109,656,289 |
RGD:6480464 |
CTD |
| G |
Dmxl2 |
Dmx-like 2 |
|
increases expression |
EXP |
9 |
54,212,965 |
54,349,433 |
RGD:6480464 |
CTD |
| G |
Dnahc14 |
dynein, axonemal, heavy chain 14 |
|
multiple interactions |
ISO |
1 |
183,671,167 |
183,699,805 |
RGD:6480464 |
CTD |
| G |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
|
affects expression |
EXP |
4 |
41,516,827 |
41,585,191 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
affects expression |
EXP |
4 |
40,669,501 |
40,684,186 |
RGD:6480464 |
CTD |
| G |
Dnaja3 |
DnaJ (Hsp40) homolog, subfamily A, member 3 |
|
affects expression |
EXP |
16 |
4,684,070 |
4,707,695 |
RGD:6480464 |
CTD |
| G |
Dnaja3 |
DnaJ (Hsp40) homolog, subfamily A, member 3 |
|
multiple interactions |
ISO |
16 |
4,684,070 |
4,707,695 |
RGD:6480464 |
CTD |
| G |
Dnajb11 |
DnaJ (Hsp40) homolog, subfamily B, member 11 |
|
affects expression |
EXP |
16 |
22,857,939 |
22,879,707 |
RGD:6480464 |
CTD |
| G |
Dnajb12 |
DnaJ (Hsp40) homolog, subfamily B, member 12 |
|
affects expression |
EXP |
10 |
59,342,339 |
59,360,764 |
RGD:6480464 |
CTD |
| G |
Dnajb12 |
DnaJ (Hsp40) homolog, subfamily B, member 12 |
|
decreases expression |
EXP |
10 |
59,342,339 |
59,360,764 |
RGD:6480464 |
CTD |
| G |
Dnajb3 |
DnaJ (Hsp40) homolog, subfamily B, member 3 |
|
affects expression |
EXP |
1 |
90,101,307 |
90,102,323 |
RGD:6480464 |
CTD |
| G |
Dnajb5 |
DnaJ (Hsp40) homolog, subfamily B, member 5 |
|
increases expression |
ISO |
4 |
42,965,966 |
42,971,604 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
affects expression |
EXP |
12 |
45,306,884 |
45,311,055 |
RGD:6480464 |
CTD |
| G |
Dnajc1 |
DnaJ (Hsp40) homolog, subfamily C, member 1 |
|
increases expression |
ISO |
2 |
18,138,762 |
18,314,134 |
RGD:6480464 |
CTD |
| G |
Dnajc1 |
DnaJ (Hsp40) homolog, subfamily C, member 1 |
|
affects expression |
EXP |
2 |
18,138,762 |
18,314,134 |
RGD:6480464 |
CTD |
| G |
Dnajc10 |
DnaJ (Hsp40) homolog, subfamily C, member 10 |
|
affects expression |
EXP |
2 |
80,155,623 |
80,194,212 |
RGD:6480464 |
CTD |
| G |
Dnajc12 |
DnaJ (Hsp40) homolog, subfamily C, member 12 |
|
increases expression |
EXP |
10 |
62,849,365 |
62,871,570 |
RGD:6480464 |
CTD |
| G |
Dnajc18 |
DnaJ (Hsp40) homolog, subfamily C, member 18 |
|
affects expression |
EXP |
18 |
35,830,757 |
35,862,798 |
RGD:6480464 |
CTD |
| G |
Dnajc3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
multiple interactions |
ISO |
14 |
119,337,154 |
119,380,924 |
RGD:6480464 |
CTD |
| G |
Dnajc4 |
DnaJ (Hsp40) homolog, subfamily C, member 4 |
|
affects expression |
EXP |
19 |
7,062,401 |
7,066,762 |
RGD:6480464 |
CTD |
| G |
Dnajc5 |
DnaJ (Hsp40) homolog, subfamily C, member 5 |
|
affects expression |
EXP |
2 |
181,255,210 |
181,286,954 |
RGD:6480464 |
CTD |
| G |
Dnajc8 |
DnaJ (Hsp40) homolog, subfamily C, member 8 |
|
multiple interactions |
ISO |
4 |
132,091,474 |
132,109,657 |
RGD:6480464 |
CTD |
| G |
Dnajc8 |
DnaJ (Hsp40) homolog, subfamily C, member 8 |
|
affects expression |
EXP |
4 |
132,091,474 |
132,109,657 |
RGD:6480464 |
CTD |
| G |
Dnase1 |
deoxyribonuclease I |
|
affects expression |
EXP |
16 |
4,037,145 |
4,040,024 |
RGD:6480464 |
CTD |
| G |
Dnm1 |
dynamin 1 |
|
increases expression |
EXP |
2 |
32,163,991 |
32,208,824 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA methyltransferase 3B |
|
decreases expression |
EXP |
2 |
153,475,190 |
153,513,466 |
RGD:6480464 |
CTD |
| G |
Dnpep |
aspartyl aminopeptidase |
|
affects expression |
EXP |
1 |
75,305,140 |
75,314,212 |
RGD:6480464 |
CTD |
| G |
Dock9 |
dedicator of cytokinesis 9 |
|
increases expression |
EXP |
14 |
121,941,261 |
122,196,956 |
RGD:6480464 |
CTD |
| G |
Dok2 |
docking protein 2 |
|
affects expression |
EXP |
14 |
71,174,188 |
71,178,301 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
increases expression |
EXP |
8 |
97,387,728 |
97,400,212 |
RGD:6480464 |
CTD |
| G |
Dopey2 |
dopey family member 2 |
|
affects expression |
EXP |
16 |
93,712,152 |
93,810,833 |
RGD:6480464 |
CTD |
| G |
Dph1 |
DPH1 homolog (S. cerevisiae) |
|
affects expression |
EXP |
11 |
74,991,145 |
75,003,985 |
RGD:6480464 |
CTD |
| G |
Dph2 |
DPH2 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
4 |
117,561,248 |
117,564,608 |
RGD:6480464 |
CTD |
| G |
Dph5 |
DPH5 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
3 |
115,591,101 |
115,632,241 |
RGD:6480464 |
CTD |
| G |
Dpm1 |
dolichol-phosphate (beta-D) mannosyltransferase 1 |
|
increases expression |
EXP |
2 |
168,034,548 |
168,055,879 |
RGD:6480464 |
CTD |
| G |
Dpp7 |
dipeptidylpeptidase 7 |
|
affects expression |
EXP |
2 |
25,207,810 |
25,211,852 |
RGD:6480464 |
CTD |
| G |
Dpy19l1 |
dpy-19-like 1 (C. elegans) |
|
affects expression |
EXP |
9 |
24,216,222 |
24,307,584 |
RGD:6480464 |
CTD |
| G |
Efnb1 |
ephrin B1 |
|
affects expression |
EXP |
X |
96,331,469 |
96,344,330 |
RGD:6480464 |
CTD |
| G |
Efs |
embryonal Fyn-associated substrate |
|
decreases expression |
ISO |
14 |
55,535,380 |
55,545,625 |
RGD:6480464 |
CTD |
| G |
Efs |
embryonal Fyn-associated substrate |
|
decreases expression |
EXP |
14 |
55,535,380 |
55,545,625 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egln1 |
EGL nine homolog 1 (C. elegans) |
|
decreases expression |
EXP |
8 |
127,432,487 |
127,473,154 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
affects expression |
EXP |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
decreases expression |
EXP |
10 |
67,000,617 |
67,004,936 |
RGD:6480464 |
CTD |
| G |
Ehbp1l1 |
EH domain binding protein 1-like 1 |
|
affects expression |
EXP |
19 |
5,707,369 |
5,726,317 |
RGD:6480464 |
CTD |
| G |
Ehd1 |
EH-domain containing 1 |
|
increases expression |
ISO |
19 |
6,276,896 |
6,300,096 |
RGD:6480464 |
CTD |
| G |
Ehd1 |
EH-domain containing 1 |
|
affects expression |
EXP |
19 |
6,276,896 |
6,300,096 |
RGD:6480464 |
CTD |
| G |
Ehd2 |
EH-domain containing 2 |
|
affects expression |
EXP |
7 |
16,534,336 |
16,552,884 |
RGD:6480464 |
CTD |
| G |
Ehd3 |
EH-domain containing 3 |
|
affects expression |
EXP |
17 |
74,154,181 |
74,181,433 |
RGD:6480464 |
CTD |
| G |
Ehd4 |
EH-domain containing 4 |
|
increases expression |
ISO |
2 |
119,915,223 |
119,980,311 |
RGD:6480464 |
CTD |
| G |
Ehhadh |
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
|
affects expression |
EXP |
16 |
21,761,358 |
21,787,907 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
multiple interactions |
ISO |
17 |
35,035,444 |
35,050,992 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
decreases expression |
ISO |
17 |
35,035,444 |
35,050,992 |
RGD:6480464 |
CTD |
| G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
|
affects expression |
EXP |
17 |
35,035,444 |
35,050,992 |
RGD:6480464 |
CTD |
| G |
Ei24 |
etoposide induced 2.4 mRNA |
|
affects expression |
EXP |
9 |
36,586,740 |
36,604,653 |
RGD:6480464 |
CTD |
| G |
Eid3 |
EP300 interacting inhibitor of differentiation 3 |
|
affects expression |
EXP |
10 |
82,329,371 |
82,330,675 |
RGD:6480464 |
CTD |
| G |
Eif1a |
eukaryotic translation initiation factor 1A |
|
affects expression |
EXP |
18 |
46,757,358 |
46,769,879 |
RGD:6480464 |
CTD |
| G |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
|
affects expression |
EXP |
5 |
144,632,731 |
144,663,586 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
affects expression |
EXP |
6 |
70,794,521 |
70,855,234 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
increases expression |
EXP |
6 |
70,794,521 |
70,855,234 |
RGD:6480464 |
CTD |
| G |
Eif2b1 |
eukaryotic translation initiation factor 2B, subunit 1 (alpha) |
|
affects expression |
EXP |
5 |
125,020,223 |
125,029,066 |
RGD:6480464 |
CTD |
| G |
Eif2b3 |
eukaryotic translation initiation factor 2B, subunit 3 |
|
affects expression |
EXP |
4 |
116,692,013 |
116,759,457 |
RGD:6480464 |
CTD |
| G |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
|
affects expression |
EXP |
5 |
31,489,931 |
31,495,512 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
affects expression |
EXP |
12 |
79,963,059 |
79,987,997 |
RGD:6480464 |
CTD |
| G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
|
decreases expression |
EXP |
19 |
60,837,019 |
60,866,596 |
RGD:6480464 |
CTD |
| G |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
|
decreases expression |
EXP |
15 |
77,789,428 |
77,801,254 |
RGD:6480464 |
CTD |
| G |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
|
affects expression |
EXP |
15 |
77,789,428 |
77,801,254 |
RGD:6480464 |
CTD |
| G |
Eif3d |
eukaryotic translation initiation factor 3, subunit D |
|
decreases expression |
ISO |
15 |
77,789,428 |
77,801,254 |
RGD:6480464 |
CTD |
| G |
Eif3g |
eukaryotic translation initiation factor 3, subunit G |
|
affects expression |
EXP |
9 |
20,698,793 |
20,703,034 |
RGD:6480464 |
CTD |
| G |
Eif3j1 |
eukaryotic translation initiation factor 3, subunit J1 |
|
affects expression |
EXP |
2 |
121,854,359 |
121,879,365 |
RGD:6480464 |
CTD |
| G |
Eif4a1 |
eukaryotic translation initiation factor 4A1 |
|
decreases expression |
EXP |
11 |
69,480,438 |
69,485,925 |
RGD:6480464 |
CTD |
| G |
Eif4a3 |
eukaryotic translation initiation factor 4A3 |
|
affects expression |
EXP |
11 |
119,149,677 |
119,161,357 |
RGD:6480464 |
CTD |
| G |
Eif4b |
eukaryotic translation initiation factor 4B |
|
multiple interactions |
ISO |
15 |
101,904,204 |
101,927,604 |
RGD:6480464 |
CTD |
| G |
Eif4e2 |
eukaryotic translation initiation factor 4E member 2 |
|
affects expression |
EXP |
1 |
89,110,489 |
89,137,063 |
RGD:6480464 |
CTD |
| G |
Eif4e3 |
eukaryotic translation initiation factor 4E member 3 |
|
affects expression |
EXP |
6 |
99,575,131 |
99,616,765 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases expression |
ISO |
8 |
28,370,799 |
28,386,128 |
RGD:6480464 |
CTD |
| G |
Eif4g3 |
eukaryotic translation initiation factor 4 gamma, 3 |
|
multiple interactions |
ISO |
4 |
137,549,385 |
137,762,398 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
EXP |
12 |
112,776,312 |
112,784,964 |
RGD:6480464 |
CTD |
| G |
Eif6 |
eukaryotic translation initiation factor 6 |
|
decreases expression |
ISO |
2 |
155,645,573 |
155,652,661 |
RGD:6480464 |
CTD |
| G |
Eif6 |
eukaryotic translation initiation factor 6 |
|
affects expression |
EXP |
2 |
155,645,573 |
155,652,661 |
RGD:6480464 |
CTD |
| G |
Elac2 |
elaC homolog 2 (E. coli) |
|
affects expression |
EXP |
11 |
64,792,537 |
64,815,578 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R) |
|
decreases expression |
ISO |
8 |
4,284,782 |
4,325,100 |
RGD:6480464 |
CTD |
| G |
Elavl1 |
ELAV (embryonic lethal, abnormal vision)-like 1 (Hu antigen R) |
|
increases expression |
ISO |
8 |
4,284,782 |
4,325,100 |
RGD:6480464 |
CTD |
| G |
Elavl2 |
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) |
|
decreases expression |
EXP |
4 |
90,917,457 |
91,066,675 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
ISO |
X |
20,510,521 |
20,527,726 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases activity |
ISO |
X |
20,510,521 |
20,527,726 |
RGD:6480464 |
CTD |
| G |
Elk3 |
ELK3, member of ETS oncogene family |
|
affects expression |
EXP |
10 |
92,710,161 |
92,773,904 |
RGD:6480464 |
CTD |
| G |
Elk3 |
ELK3, member of ETS oncogene family |
|
multiple interactions |
ISO |
10 |
92,710,161 |
92,773,904 |
RGD:6480464 |
CTD |
| G |
Ell |
elongation factor RNA polymerase II |
|
multiple interactions |
ISO |
8 |
73,063,574 |
73,116,757 |
RGD:6480464 |
CTD |
| G |
Ell2 |
elongation factor RNA polymerase II 2 |
|
increases expression |
ISO |
13 |
75,844,932 |
75,909,809 |
RGD:6480464 |
CTD |
| G |
Ell3 |
elongation factor RNA polymerase II-like 3 |
|
multiple interactions |
ISO |
2 |
121,264,763 |
121,268,337 |
RGD:6480464 |
CTD |
| G |
Ell3 |
elongation factor RNA polymerase II-like 3 |
|
affects expression |
EXP |
2 |
121,264,763 |
121,268,337 |
RGD:6480464 |
CTD |
| G |
Elmo3 |
engulfment and cell motility 3 |
|
affects expression |
EXP |
8 |
107,829,501 |
107,834,523 |
RGD:6480464 |
CTD |
| G |
Elof1 |
elongation factor 1 homolog (ELF1, S. cerevisiae) |
|
affects expression |
EXP |
9 |
21,917,433 |
21,918,613 |
RGD:6480464 |
CTD |
| G |
Ermp1 |
endoplasmic reticulum metallopeptidase 1 |
|
increases expression |
ISO |
19 |
29,684,373 |
29,722,910 |
RGD:6480464 |
CTD |
| G |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
|
affects expression |
EXP |
4 |
150,229,200 |
150,242,989 |
RGD:6480464 |
CTD |
| G |
Esd |
esterase D/formylglutathione hydrolase |
|
increases expression |
ISO |
14 |
75,132,152 |
75,150,250 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esyt1 |
extended synaptotagmin-like protein 1 |
|
increases expression |
EXP |
10 |
127,947,304 |
127,962,915 |
RGD:6480464 |
CTD |
| G |
Etaa1 |
Ewing's tumor-associated antigen 1 |
|
affects expression |
EXP |
11 |
17,838,752 |
17,853,878 |
RGD:6480464 |
CTD |
| G |
Etf1 |
eukaryotic translation termination factor 1 |
|
affects expression |
EXP |
18 |
35,062,439 |
35,091,657 |
RGD:6480464 |
CTD |
| G |
Etfdh |
electron transferring flavoprotein, dehydrogenase |
|
affects expression |
EXP |
3 |
79,407,710 |
79,432,689 |
RGD:6480464 |
CTD |
| G |
Ethe1 |
ethylmalonic encephalopathy 1 |
|
affects expression |
EXP |
7 |
25,372,562 |
25,393,944 |
RGD:6480464 |
CTD |
| G |
Ethe1 |
ethylmalonic encephalopathy 1 |
|
increases expression |
EXP |
7 |
25,372,562 |
25,393,944 |
RGD:6480464 |
CTD |
| G |
Ets1 |
E26 avian leukemia oncogene 1, 5' domain |
|
increases expression |
ISO |
9 |
32,503,627 |
32,565,405 |
RGD:6480464 |
CTD |
| G |
Etv5 |
ets variant gene 5 |
|
decreases expression |
EXP |
16 |
22,381,386 |
22,439,643 |
RGD:6480464 |
CTD |
| G |
Etv6 |
ets variant gene 6 (TEL oncogene) |
|
affects expression |
EXP |
6 |
133,985,725 |
134,220,176 |
RGD:6480464 |
CTD |
| G |
Evc2 |
Ellis van Creveld syndrome 2 |
|
decreases expression |
EXP |
5 |
37,729,717 |
37,816,293 |
RGD:6480464 |
CTD |
| G |
Evc2 |
Ellis van Creveld syndrome 2 |
|
increases expression |
EXP |
5 |
37,729,717 |
37,816,293 |
RGD:6480464 |
CTD |
| G |
Evi2b |
ecotropic viral integration site 2b |
|
affects expression |
EXP |
11 |
79,326,887 |
79,344,091 |
RGD:6480464 |
CTD |
| G |
Evi5l |
ecotropic viral integration site 5 like |
|
increases expression |
EXP |
8 |
4,166,567 |
4,193,701 |
RGD:6480464 |
CTD |
| G |
Ewsr1 |
Ewing sarcoma breakpoint region 1 |
|
affects expression |
EXP |
11 |
4,969,691 |
4,999,080 |
RGD:6480464 |
CTD |
| G |
Exo1 |
exonuclease 1 |
|
decreases expression |
EXP |
1 |
177,810,909 |
177,841,527 |
RGD:6480464 |
CTD |
| G |
Exoc3l2 |
exocyst complex component 3-like 2 |
|
multiple interactions |
ISO |
7 |
20,063,253 |
20,082,111 |
RGD:6480464 |
CTD |
| G |
Exoc7 |
exocyst complex component 7 |
|
multiple interactions |
ISO |
11 |
116,149,312 |
116,168,052 |
RGD:6480464 |
CTD |
| G |
Exoc7 |
exocyst complex component 7 |
|
affects expression |
EXP |
11 |
116,149,312 |
116,168,052 |
RGD:6480464 |
CTD |
| G |
Exosc1 |
exosome component 1 |
|
affects expression |
EXP |
19 |
41,997,470 |
42,007,804 |
RGD:6480464 |
CTD |
| G |
Exosc4 |
exosome component 4 |
|
affects expression |
EXP |
15 |
76,157,827 |
76,161,100 |
RGD:6480464 |
CTD |
| G |
Exosc9 |
exosome component 9 |
|
affects expression |
EXP |
3 |
36,451,528 |
36,464,649 |
RGD:6480464 |
CTD |
| G |
Extl1 |
exostoses (multiple)-like 1 |
|
affects expression |
EXP |
4 |
133,912,288 |
133,928,462 |
RGD:6480464 |
CTD |
| G |
Eya3 |
eyes absent 3 homolog (Drosophila) |
|
affects expression |
EXP |
4 |
132,194,961 |
132,280,678 |
RGD:6480464 |
CTD |
| G |
Ezh2 |
enhancer of zeste homolog 2 (Drosophila) |
|
affects expression |
EXP |
6 |
47,480,273 |
47,545,029 |
RGD:6480464 |
CTD |
| G |
F10 |
coagulation factor X |
|
decreases expression |
ISO |
8 |
13,037,308 |
13,056,216 |
RGD:6480464 |
CTD |
| G |
F11r |
F11 receptor |
|
multiple interactions |
ISO |
1 |
173,367,692 |
173,394,724 |
RGD:6480464 |
CTD |
| G |
F12 |
coagulation factor XII (Hageman factor) |
|
multiple interactions |
ISO |
13 |
55,519,327 |
55,528,163 |
RGD:6480464 |
CTD |
| G |
F13a1 |
coagulation factor XIII, A1 subunit |
|
decreases expression |
ISO |
13 |
36,959,047 |
37,142,113 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
decreases expression |
EXP |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
increases expression |
ISO |
13 |
96,281,673 |
96,295,195 |
RGD:6480464 |
CTD |
| G |
F2rl1 |
coagulation factor II (thrombin) receptor-like 1 |
|
decreases expression |
EXP |
13 |
96,281,673 |
96,295,195 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
increases expression |
ISO |
6 |
71,149,882 |
71,155,017 |
RGD:6480464 |
CTD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
affects response to substance |
ISO |
3 |
122,598,310 |
122,602,424 |
RGD:6480464 |
CTD |
| G |
Fabp6 |
fatty acid binding protein 6, ileal (gastrotropin) |
|
affects expression |
EXP |
11 |
43,409,614 |
43,415,013 |
RGD:6480464 |
CTD |
| G |
Fabp9 |
fatty acid binding protein 9, testis |
|
affects expression |
EXP |
3 |
10,193,628 |
10,197,222 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
affects expression |
EXP |
19 |
10,257,378 |
10,271,364 |
RGD:6480464 |
CTD |
| G |
Fads2 |
fatty acid desaturase 2 |
|
decreases expression |
EXP |
19 |
10,138,654 |
10,175,993 |
RGD:6480464 |
CTD |
| G |
Fads3 |
fatty acid desaturase 3 |
|
increases expression |
ISO |
19 |
10,116,038 |
10,134,161 |
RGD:6480464 |
CTD |
| G |
Faf1 |
Fas-associated factor 1 |
|
affects expression |
EXP |
4 |
109,349,232 |
109,636,565 |
RGD:6480464 |
CTD |
| G |
Faf2 |
Fas associated factor family member 2 |
|
affects expression |
EXP |
13 |
54,723,145 |
54,765,424 |
RGD:6480464 |
CTD |
| G |
Fah |
fumarylacetoacetate hydrolase |
|
increases expression |
ISO |
7 |
91,733,669 |
91,754,452 |
RGD:6480464 |
CTD |
| G |
Faim |
Fas apoptotic inhibitory molecule |
|
decreases expression |
ISO |
9 |
98,886,792 |
98,902,438 |
RGD:6480464 |
CTD |
| G |
Faim |
Fas apoptotic inhibitory molecule |
|
increases expression |
EXP |
9 |
98,886,792 |
98,902,438 |
RGD:6480464 |
CTD |
| G |
Fam110c |
family with sequence similarity 110, member C |
|
affects expression |
EXP |
12 |
31,758,833 |
31,764,805 |
RGD:6480464 |
CTD |
| G |
Fam115c |
family with sequence similarity 115, member C |
|
increases expression |
EXP |
6 |
42,573,042 |
42,595,040 |
RGD:6480464 |
CTD |
| G |
Fam117a |
family with sequence similarity 117, member A |
|
affects expression |
EXP |
11 |
95,198,332 |
95,243,186 |
RGD:6480464 |
CTD |
| G |
Fam124b |
family with sequence similarity 124, member B |
|
affects expression |
EXP |
1 |
80,195,274 |
80,210,519 |
RGD:6480464 |
CTD |
| G |
Fam126a |
family with sequence similarity 126, member A |
|
increases expression |
ISO |
5 |
23,466,749 |
23,536,501 |
RGD:6480464 |
CTD |
| G |
Fam126a |
family with sequence similarity 126, member A |
|
increases expression |
EXP |
5 |
23,466,749 |
23,536,501 |
RGD:6480464 |
CTD |
| G |
Fam129a |
family with sequence similarity 129, member A |
|
increases expression |
ISO |
1 |
153,418,503 |
153,566,477 |
RGD:6480464 |
CTD |
| G |
Fam129b |
family with sequence similarity 129, member B |
|
affects expression |
EXP |
2 |
32,731,654 |
32,780,773 |
RGD:6480464 |
CTD |
| G |
Fam131a |
family with sequence similarity 131, member A |
|
affects expression |
EXP |
16 |
20,695,130 |
20,703,109 |
RGD:6480464 |
CTD |
| G |
Fam131b |
family with sequence similarity 131, member B |
|
increases expression |
ISO |
6 |
42,265,311 |
42,274,639 |
RGD:6480464 |
CTD |
| G |
Fam134b |
family with sequence similarity 134, member B |
|
increases expression |
ISO |
15 |
25,773,019 |
25,903,442 |
RGD:6480464 |
CTD |
| G |
Fam13b |
family with sequence similarity 13, member B |
|
multiple interactions |
ISO |
18 |
34,602,005 |
34,666,477 |
RGD:6480464 |
CTD |
| G |
Fam149b |
family with sequence similarity 149, member B |
|
affects expression |
EXP |
14 |
21,167,384 |
21,202,713 |
RGD:6480464 |
CTD |
| G |
Fbxl20 |
F-box and leucine-rich repeat protein 20 |
|
increases expression |
EXP |
11 |
97,943,868 |
98,010,930 |
RGD:6480464 |
CTD |
| G |
Fbxl8 |
F-box and leucine-rich repeat protein 8 |
|
affects expression |
EXP |
8 |
107,788,548 |
107,793,226 |
RGD:6480464 |
CTD |
| G |
Fbxl8 |
F-box and leucine-rich repeat protein 8 |
|
increases expression |
EXP |
8 |
107,788,548 |
107,793,226 |
RGD:6480464 |
CTD |
| G |
Fbxo2 |
F-box protein 2 |
|
increases expression |
ISO |
4 |
147,534,777 |
147,540,526 |
RGD:6480464 |
CTD |
| G |
Fbxo2 |
F-box protein 2 |
|
increases expression |
EXP |
4 |
147,534,777 |
147,540,526 |
RGD:6480464 |
CTD |
| G |
Fbxo21 |
F-box protein 21 |
|
affects expression |
EXP |
5 |
118,426,779 |
118,460,200 |
RGD:6480464 |
CTD |
| G |
Fbxo25 |
F-box protein 25 |
|
increases expression |
ISO |
8 |
13,907,806 |
13,940,521 |
RGD:6480464 |
CTD |
| G |
Fbxo28 |
F-box protein 28 |
|
decreases expression |
EXP |
1 |
184,243,233 |
184,271,737 |
RGD:6480464 |
CTD |
| G |
Fbxo39 |
F-box protein 39 |
|
affects expression |
EXP |
11 |
72,127,946 |
72,132,921 |
RGD:6480464 |
CTD |
| G |
Fbxo43 |
F-box protein 43 |
|
affects expression |
EXP |
15 |
36,079,815 |
36,094,639 |
RGD:6480464 |
CTD |
| G |
Fbxo5 |
F-box protein 5 |
|
decreases expression |
EXP |
10 |
4,541,076 |
4,547,383 |
RGD:6480464 |
CTD |
| G |
Fbxo6 |
F-box protein 6 |
|
affects expression |
EXP |
4 |
147,519,825 |
147,526,244 |
RGD:6480464 |
CTD |
| G |
Fbxo7 |
F-box protein 7 |
|
affects expression |
EXP |
10 |
85,484,674 |
85,511,073 |
RGD:6480464 |
CTD |
| G |
Fbxo9 |
f-box protein 9 |
|
increases expression |
ISO |
9 |
77,929,306 |
77,956,860 |
RGD:6480464 |
CTD |
| G |
Fbxo9 |
f-box protein 9 |
|
affects expression |
EXP |
9 |
77,929,306 |
77,956,860 |
RGD:6480464 |
CTD |
| G |
Fbxw4 |
F-box and WD-40 domain protein 4 |
|
multiple interactions |
ISO |
19 |
45,652,747 |
45,734,683 |
RGD:6480464 |
CTD |
| G |
Fbxw9 |
F-box and WD-40 domain protein 9 |
|
affects expression |
EXP |
8 |
87,584,018 |
87,591,020 |
RGD:6480464 |
CTD |
| G |
Fcer1a |
Fc receptor, IgE, high affinity I, alpha polypeptide |
|
affects expression |
EXP |
1 |
175,151,402 |
175,157,360 |
RGD:6480464 |
CTD |
| G |
Fcho1 |
FCH domain only 1 |
|
affects expression |
EXP |
8 |
74,232,286 |
74,249,580 |
RGD:6480464 |
CTD |
| G |
Fchsd1 |
FCH and double SH3 domains 1 |
|
affects expression |
EXP |
18 |
38,117,088 |
38,129,385 |
RGD:6480464 |
CTD |
| G |
Fcrla |
Fc receptor-like A |
|
affects expression |
EXP |
1 |
172,847,725 |
172,857,714 |
RGD:6480464 |
CTD |
| G |
Fcrls |
Fc receptor-like S, scavenger receptor |
|
affects expression |
EXP |
3 |
87,054,887 |
87,067,446 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
increases expression |
ISO |
14 |
63,763,987 |
63,796,630 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
affects expression |
EXP |
14 |
63,763,987 |
63,796,630 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthetase |
|
affects expression |
EXP |
3 |
88,897,510 |
88,905,867 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthetase |
|
multiple interactions |
ISO |
3 |
88,897,510 |
88,905,867 |
RGD:6480464 |
CTD |
| G |
Fermt2 |
fermitin family homolog 2 (Drosophila) |
|
affects expression |
EXP |
14 |
46,078,467 |
46,149,740 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
increases expression |
ISO |
9 |
36,651,244 |
36,686,225 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
increases expression |
EXP |
9 |
36,651,244 |
36,686,225 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
affects expression |
EXP |
9 |
36,651,244 |
36,686,225 |
RGD:6480464 |
CTD |
| G |
Ffar2 |
free fatty acid receptor 2 |
|
affects expression |
EXP |
7 |
31,603,376 |
31,608,794 |
RGD:6480464 |
CTD |
| G |
Ffar3 |
free fatty acid receptor 3 |
|
multiple interactions |
ISO |
7 |
31,639,349 |
31,641,197 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 |
|
affects expression |
EXP |
18 |
38,998,327 |
39,078,353 |
RGD:6480464 |
CTD |
| G |
Fgf12 |
fibroblast growth factor 12 |
|
affects expression |
EXP |
16 |
28,160,184 |
28,753,288 |
RGD:6480464 |
CTD |
| G |
Fgf15 |
fibroblast growth factor 15 |
|
decreases expression |
EXP |
7 |
152,082,437 |
152,086,858 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
affects expression |
EXP |
7 |
52,869,260 |
52,870,860 |
RGD:6480464 |
CTD |
| G |
Fgf21 |
fibroblast growth factor 21 |
|
decreases expression |
EXP |
7 |
52,869,260 |
52,870,860 |
RGD:6480464 |
CTD |
| G |
Fgf23 |
fibroblast growth factor 23 |
|
affects expression |
EXP |
6 |
127,022,920 |
127,031,426 |
RGD:6480464 |
CTD |
| G |
Fgf3 |
fibroblast growth factor 3 |
|
affects expression |
EXP |
7 |
152,024,517 |
152,029,253 |
RGD:6480464 |
CTD |
| G |
Fgf4 |
fibroblast growth factor 4 |
|
affects expression |
EXP |
7 |
152,047,291 |
152,051,148 |
RGD:6480464 |
CTD |
| G |
Fgf4 |
fibroblast growth factor 4 |
|
decreases expression |
EXP |
7 |
152,047,291 |
152,051,148 |
RGD:6480464 |
CTD |
| G |
Fgf8 |
fibroblast growth factor 8 |
|
multiple interactions |
EXP |
19 |
45,811,288 |
45,817,374 |
RGD:6480464 |
CTD |
| G |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
|
affects expression |
EXP |
19 |
36,992,040 |
36,994,089 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
increases expression |
ISO |
5 |
34,064,373 |
34,079,713 |
RGD:6480464 |
CTD |
| G |
Fgl1 |
fibrinogen-like protein 1 |
|
affects expression |
EXP |
8 |
42,276,788 |
42,300,510 |
RGD:6480464 |
CTD |
| G |
Fh1 |
fumarate hydratase 1 |
|
affects expression |
EXP |
1 |
177,531,509 |
177,555,766 |
RGD:6480464 |
CTD |
| G |
Fhdc1 |
FH2 domain containing 1 |
|
affects expression |
EXP |
3 |
84,247,947 |
84,284,351 |
RGD:6480464 |
CTD |
| G |
Fhl3 |
four and a half LIM domains 3 |
|
affects expression |
EXP |
4 |
124,377,943 |
124,385,855 |
RGD:6480464 |
CTD |
| G |
Fhl5 |
four and a half LIM domains 5 |
|
affects expression |
EXP |
4 |
25,127,056 |
25,170,023 |
RGD:6480464 |
CTD |
| G |
Fibp |
fibroblast growth factor (acidic) intracellular binding protein |
|
affects expression |
EXP |
19 |
5,460,694 |
5,464,994 |
RGD:6480464 |
CTD |
| G |
Fig4 |
FIG4 homolog (S. cerevisiae) |
|
increases expression |
EXP |
10 |
40,907,978 |
41,023,047 |
RGD:6480464 |
CTD |
| G |
Fig4 |
FIG4 homolog (S. cerevisiae) |
|
affects expression |
EXP |
10 |
40,907,978 |
41,023,047 |
RGD:6480464 |
CTD |
| G |
Fis1 |
fission 1 (mitochondrial outer membrane) homolog (yeast) |
|
multiple interactions |
ISO |
5 |
137,429,145 |
137,442,104 |
RGD:6480464 |
CTD |
| G |
Fitm1 |
fat storage-inducing transmembrane protein 1 |
|
affects expression |
EXP |
14 |
56,194,511 |
56,195,789 |
RGD:6480464 |
CTD |
| G |
Fiz1 |
Flt3 interacting zinc finger protein 1 |
|
decreases expression |
ISO |
7 |
4,958,658 |
4,966,330 |
RGD:6480464 |
CTD |
| G |
Fiz1 |
Flt3 interacting zinc finger protein 1 |
|
affects expression |
EXP |
7 |
4,958,658 |
4,966,330 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
affects expression |
EXP |
15 |
98,554,799 |
98,558,629 |
RGD:6480464 |
CTD |
| G |
Fkbp1b |
FK506 binding protein 1b |
|
affects expression |
EXP |
12 |
4,839,980 |
4,848,401 |
RGD:6480464 |
CTD |
| G |
Fkbp1b |
FK506 binding protein 1b |
|
increases expression |
ISO |
12 |
4,839,980 |
4,848,401 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
decreases expression |
EXP |
17 |
28,536,040 |
28,578,001 |
RGD:6480464 |
CTD |
| G |
Fkbp7 |
FK506 binding protein 7 |
|
affects expression |
EXP |
2 |
76,501,091 |
76,511,155 |
RGD:6480464 |
CTD |
| G |
Fkbp8 |
FK506 binding protein 8 |
|
affects expression |
EXP |
8 |
73,051,642 |
73,059,227 |
RGD:6480464 |
CTD |
| G |
Fkbp8 |
FK506 binding protein 8 |
|
decreases expression |
EXP |
8 |
73,051,642 |
73,059,227 |
RGD:6480464 |
CTD |
| G |
Fli1 |
Friend leukemia integration 1 |
|
affects expression |
EXP |
9 |
32,229,793 |
32,348,953 |
RGD:6480464 |
CTD |
| G |
Flot1 |
flotillin 1 |
|
increases expression |
ISO |
17 |
35,960,302 |
35,969,732 |
RGD:6480464 |
CTD |
| G |
Flot1 |
flotillin 1 |
|
multiple interactions |
ISO |
17 |
35,960,302 |
35,969,732 |
RGD:6480464 |
CTD |
| G |
Fmn2 |
formin 2 |
|
affects expression |
EXP |
1 |
176,431,956 |
176,752,860 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
affects expression |
EXP |
1 |
164,759,692 |
164,796,679 |
RGD:6480464 |
CTD |
| G |
Fmo2 |
flavin containing monooxygenase 2 |
|
affects expression |
EXP |
1 |
164,805,178 |
164,828,843 |
RGD:6480464 |
CTD |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
|
affects expression |
EXP |
17 |
37,182,911 |
37,211,250 |
RGD:6480464 |
CTD |
| G |
Gabpa |
GA repeat binding protein, alpha |
|
multiple interactions |
ISO |
16 |
84,835,369 |
84,864,024 |
RGD:6480464 |
CTD |
| G |
Gabra3 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
|
affects expression |
EXP |
X |
69,678,015 |
69,901,585 |
RGD:6480464 |
CTD |
| G |
Gabra5 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 |
|
affects expression |
EXP |
7 |
64,663,039 |
64,765,379 |
RGD:6480464 |
CTD |
| G |
Gabra6 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6 |
|
affects expression |
EXP |
11 |
42,119,939 |
42,134,553 |
RGD:6480464 |
CTD |
| G |
Gabrd |
gamma-aminobutyric acid (GABA) A receptor, subunit delta |
|
decreases expression |
ISO |
4 |
154,759,088 |
154,772,178 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
EXP |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
EXP |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
EXP |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
EXP |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
decreases methylation |
EXP |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
increases expression |
EXP |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
increases expression |
ISO |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamic acid decarboxylase 2 |
|
affects expression |
EXP |
2 |
22,477,847 |
22,549,397 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamic acid decarboxylase 2 |
|
increases expression |
ISO |
2 |
22,477,847 |
22,549,397 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamic acid decarboxylase 2 |
|
decreases expression |
ISO |
2 |
22,477,847 |
22,549,397 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
decreases expression |
EXP |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
|
affects expression |
EXP |
10 |
80,392,836 |
80,394,949 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible 45 beta |
|
increases expression |
EXP |
10 |
80,392,836 |
80,394,949 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible 45 gamma |
|
decreases expression |
EXP |
13 |
51,942,044 |
51,943,844 |
RGD:6480464 |
CTD |
| G |
Gadd45gip1 |
growth arrest and DNA-damage-inducible, gamma interacting protein 1 |
|
decreases expression |
EXP |
8 |
87,356,181 |
87,359,381 |
RGD:6480464 |
CTD |
| G |
Gak |
cyclin G associated kinase |
|
affects expression |
EXP |
5 |
108,998,433 |
109,058,758 |
RGD:6480464 |
CTD |
| G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
|
increases expression |
EXP |
11 |
3,883,639 |
3,899,331 |
RGD:6480464 |
CTD |
| G |
Gal3st4 |
galactose-3-O-sulfotransferase 4 |
|
affects expression |
EXP |
5 |
138,706,153 |
138,713,982 |
RGD:6480464 |
CTD |
| G |
Gale |
galactose-4-epimerase, UDP |
|
affects expression |
EXP |
4 |
135,521,080 |
135,524,093 |
RGD:6480464 |
CTD |
| G |
Gale |
galactose-4-epimerase, UDP |
|
increases expression |
ISO |
4 |
135,521,080 |
135,524,093 |
RGD:6480464 |
CTD |
| G |
Galm |
galactose mutarotase |
|
affects expression |
EXP |
17 |
80,526,811 |
80,584,372 |
RGD:6480464 |
CTD |
| G |
Galns |
galactosamine (N-acetyl)-6-sulfate sulfatase |
|
affects expression |
EXP |
8 |
125,102,137 |
125,135,241 |
RGD:6480464 |
CTD |
| G |
Galnt1 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
|
affects expression |
EXP |
18 |
24,363,845 |
24,445,317 |
RGD:6480464 |
CTD |
| G |
Galnt12 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 |
|
increases expression |
EXP |
4 |
47,104,825 |
47,135,914 |
RGD:6480464 |
CTD |
| G |
Galnt16 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
|
increases expression |
ISO |
12 |
81,619,977 |
81,704,883 |
RGD:6480464 |
CTD |
| G |
Galnt7 |
UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 |
|
multiple interactions |
ISO |
8 |
60,002,622 |
60,131,852 |
RGD:6480464 |
CTD |
| G |
Galp |
galanin-like peptide |
|
multiple interactions |
ISO |
7 |
6,148,692 |
6,167,739 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
decreases expression |
EXP |
11 |
116,142,253 |
116,145,252 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
increases expression |
EXP |
11 |
116,142,253 |
116,145,252 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate methyltransferase |
|
affects expression |
EXP |
10 |
79,720,896 |
79,723,713 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate methyltransferase |
|
multiple interactions |
ISO |
10 |
79,720,896 |
79,723,713 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate methyltransferase |
|
increases expression |
EXP |
10 |
79,720,896 |
79,723,713 |
RGD:6480464 |
CTD |
| G |
Ganab |
alpha glucosidase 2 alpha neutral subunit |
|
multiple interactions |
ISO |
19 |
8,972,601 |
8,991,156 |
RGD:6480464 |
CTD |
| G |
Gap43 |
growth associated protein 43 |
|
increases expression |
ISO |
16 |
42,248,665 |
42,340,764 |
RGD:6480464 |
CTD |
| G |
Gar1 |
GAR1 ribonucleoprotein homolog (yeast) |
|
decreases expression |
EXP |
3 |
129,527,830 |
129,534,314 |
RGD:6480464 |
CTD |
| G |
Gars |
glycyl-tRNA synthetase |
|
affects expression |
EXP |
6 |
54,987,995 |
55,029,498 |
RGD:6480464 |
CTD |
| G |
Gas1 |
growth arrest specific 1 |
|
affects expression |
EXP |
13 |
60,275,766 |
60,278,896 |
RGD:6480464 |
CTD |
| G |
Gas2 |
growth arrest specific 2 |
|
increases expression |
ISO |
7 |
59,134,515 |
59,249,828 |
RGD:6480464 |
CTD |
| G |
Gas2 |
growth arrest specific 2 |
|
decreases expression |
EXP |
7 |
59,134,515 |
59,249,828 |
RGD:6480464 |
CTD |
| G |
Gas2l1 |
growth arrest-specific 2 like 1 |
|
increases expression |
EXP |
11 |
4,954,134 |
4,965,330 |
RGD:6480464 |
CTD |
| G |
Gata3 |
GATA binding protein 3 |
|
affects expression |
EXP |
2 |
9,778,705 |
9,800,227 |
RGD:6480464 |
CTD |
| G |
Gata3 |
GATA binding protein 3 |
|
increases expression |
ISO |
2 |
9,778,705 |
9,800,227 |
RGD:6480464 |
CTD |
| G |
Gatad1 |
GATA zinc finger domain containing 1 |
|
affects expression |
EXP |
5 |
3,639,961 |
3,647,936 |
RGD:6480464 |
CTD |
| G |
Gatad2a |
GATA zinc finger domain containing 2A |
|
affects expression |
EXP |
8 |
72,430,968 |
72,520,278 |
RGD:6480464 |
CTD |
| G |
Gatm |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
increases expression |
ISO |
2 |
122,420,209 |
122,437,013 |
RGD:6480464 |
CTD |
| G |
Gatm |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
affects expression |
EXP |
2 |
122,420,209 |
122,437,013 |
RGD:6480464 |
CTD |
| G |
Gba2 |
glucosidase beta 2 |
|
affects expression |
EXP |
4 |
43,579,800 |
43,591,736 |
RGD:6480464 |
CTD |
| G |
Gcc2 |
GRIP and coiled-coil domain containing 2 |
|
affects expression |
EXP |
10 |
57,718,274 |
57,768,340 |
RGD:6480464 |
CTD |
| G |
Gch1 |
GTP cyclohydrolase 1 |
|
increases expression |
EXP |
14 |
47,773,570 |
47,809,077 |
RGD:6480464 |
CTD |
| G |
Gdap10 |
ganglioside-induced differentiation-associated-protein 10 |
|
affects expression |
EXP |
12 |
33,508,500 |
33,510,095 |
RGD:6480464 |
CTD |
| G |
Gm11563 |
predicted gene 11563 |
|
multiple interactions |
ISO |
11 |
99,519,256 |
99,520,273 |
RGD:6480464 |
CTD |
| G |
Gm9571 |
predicted gene 9571 |
|
multiple interactions |
ISO |
7 |
112,857,038 |
112,870,313 |
RGD:6480464 |
CTD |
| G |
Golt1b |
golgi transport 1 homolog B (S. cerevisiae) |
|
decreases expression |
EXP |
6 |
142,335,763 |
142,352,378 |
RGD:6480464 |
CTD |
| G |
Got2 |
glutamate oxaloacetate transaminase 2, mitochondrial |
|
multiple interactions |
ISO |
8 |
98,388,037 |
98,412,265 |
RGD:6480464 |
CTD |
| G |
Gp2 |
glycoprotein 2 (zymogen granule membrane) |
|
multiple interactions |
ISO |
7 |
126,586,058 |
126,602,786 |
RGD:6480464 |
CTD |
| G |
Gpa33 |
glycoprotein A33 (transmembrane) |
|
affects expression |
EXP |
1 |
168,060,591 |
168,096,641 |
RGD:6480464 |
CTD |
| G |
Gpaa1 |
GPI anchor attachment protein 1 |
|
multiple interactions |
ISO |
15 |
76,161,724 |
76,165,329 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
ISO |
19 |
55,144,224 |
55,173,937 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
affects expression |
EXP |
19 |
55,144,224 |
55,173,937 |
RGD:6480464 |
CTD |
| G |
Gpank1 |
G patch domain and ankyrin repeats 1 |
|
affects expression |
EXP |
17 |
35,258,441 |
35,261,760 |
RGD:6480464 |
CTD |
| G |
Gpatch2 |
G patch domain containing 2 |
|
affects expression |
EXP |
1 |
189,039,390 |
189,175,324 |
RGD:6480464 |
CTD |
| G |
Gpatch3 |
G patch domain containing 3 |
|
affects expression |
EXP |
4 |
133,130,660 |
133,140,157 |
RGD:6480464 |
CTD |
| G |
Gpatch4 |
G patch domain containing 4 |
|
decreases expression |
ISO |
3 |
87,847,030 |
87,859,915 |
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
affects expression |
EXP |
1 |
94,728,263 |
94,756,773 |
RGD:6480464 |
CTD |
| G |
Gpc4 |
glypican 4 |
|
increases expression |
ISO |
X |
49,406,195 |
49,518,100 |
RGD:6480464 |
CTD |
| G |
Gpm6a |
glycoprotein m6a |
|
increases expression |
ISO |
8 |
56,040,081 |
56,146,231 |
RGD:6480464 |
CTD |
| G |
Gpn2 |
GPN-loop GTPase 2 |
|
affects expression |
EXP |
4 |
133,140,288 |
133,147,650 |
RGD:6480464 |
CTD |
| G |
Gpr110 |
G protein-coupled receptor 110 |
|
affects expression |
EXP |
17 |
43,407,296 |
43,461,355 |
RGD:6480464 |
CTD |
| G |
Gpr119 |
G-protein coupled receptor 119 |
|
affects expression |
EXP |
X |
46,021,156 |
46,027,655 |
RGD:6480464 |
CTD |
| G |
Gpr12 |
G-protein coupled receptor 12 |
|
affects expression |
EXP |
5 |
147,393,726 |
147,396,815 |
RGD:6480464 |
CTD |
| G |
Gpr125 |
G protein-coupled receptor 125 |
|
multiple interactions |
ISO |
5 |
50,351,190 |
50,450,235 |
RGD:6480464 |
CTD |
| G |
Gpr137b |
G protein-coupled receptor 137B |
|
affects expression |
EXP |
13 |
13,449,887 |
13,485,891 |
RGD:6480464 |
CTD |
| G |
Gpr153 |
G protein-coupled receptor 153 |
|
increases expression |
EXP |
4 |
151,648,471 |
151,659,446 |
RGD:6480464 |
CTD |
| G |
Gpr157 |
G protein-coupled receptor 157 |
|
affects expression |
EXP |
4 |
149,461,612 |
149,480,036 |
RGD:6480464 |
CTD |
| G |
Gpr160 |
G protein-coupled receptor 160 |
|
increases expression |
EXP |
3 |
30,754,872 |
30,796,114 |
RGD:6480464 |
CTD |
| G |
Gpr161 |
G protein-coupled receptor 161 |
|
increases expression |
EXP |
1 |
167,225,897 |
167,251,982 |
RGD:6480464 |
CTD |
| G |
Gpr180 |
G protein-coupled receptor 180 |
|
affects expression |
EXP |
14 |
118,536,349 |
118,563,454 |
RGD:6480464 |
CTD |
| G |
Gpr183 |
G protein-coupled receptor 183 |
|
affects expression |
EXP |
14 |
122,351,553 |
122,364,415 |
RGD:6480464 |
CTD |
| G |
Gpr19 |
G protein-coupled receptor 19 |
|
decreases expression |
EXP |
6 |
134,819,111 |
134,847,943 |
RGD:6480464 |
CTD |
| G |
Gpr33 |
G protein-coupled receptor 33 |
|
affects expression |
EXP |
12 |
53,123,990 |
53,129,050 |
RGD:6480464 |
CTD |
| G |
Gpr37 |
G protein-coupled receptor 37 |
|
increases expression |
ISO |
6 |
25,618,523 |
25,639,980 |
RGD:6480464 |
CTD |
| G |
Gpr62 |
G protein-coupled receptor 62 |
|
affects expression |
EXP |
9 |
106,366,291 |
106,368,271 |
RGD:6480464 |
CTD |
| G |
Gpr83 |
G protein-coupled receptor 83 |
|
multiple interactions |
ISO |
9 |
14,664,698 |
14,673,943 |
RGD:6480464 |
CTD |
| G |
Gpr87 |
G protein-coupled receptor 87 |
|
affects expression |
EXP |
3 |
58,982,845 |
58,984,007 |
RGD:6480464 |
CTD |
| G |
Gpr89 |
G protein-coupled receptor 89 |
|
affects expression |
EXP |
3 |
96,674,989 |
96,709,221 |
RGD:6480464 |
CTD |
| G |
Gpr98 |
G protein-coupled receptor 98 |
|
affects expression |
EXP |
13 |
81,234,067 |
81,772,143 |
RGD:6480464 |
CTD |
| G |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
|
affects expression |
EXP |
X |
132,277,231 |
132,338,007 |
RGD:6480464 |
CTD |
| G |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
|
increases expression |
ISO |
X |
132,277,231 |
132,338,007 |
RGD:6480464 |
CTD |
| G |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
|
increases expression |
EXP |
X |
132,277,231 |
132,338,007 |
RGD:6480464 |
CTD |
| G |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
|
increases expression |
EXP |
13 |
54,838,034 |
54,851,030 |
RGD:6480464 |
CTD |
| G |
Gprin3 |
GPRIN family member 3 |
|
affects expression |
EXP |
6 |
59,302,455 |
59,376,284 |
RGD:6480464 |
CTD |
| G |
Gps2 |
G protein pathway suppressor 2 |
|
multiple interactions |
ISO |
11 |
69,727,694 |
69,730,093 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
multiple interactions |
ISO |
15 |
76,527,194 |
76,530,105 |
RGD:6480464 |
CTD |
| G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
affects expression |
EXP |
8 |
88,016,516 |
88,051,457 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
ISO |
11 |
54,716,355 |
54,723,889 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
affects expression |
EXP |
10 |
79,516,255 |
79,519,184 |
RGD:6480464 |
CTD |
| G |
Gpx7 |
glutathione peroxidase 7 |
|
affects expression |
EXP |
4 |
108,072,822 |
108,079,318 |
RGD:6480464 |
CTD |
| G |
Gramd3 |
GRAM domain containing 3 |
|
affects expression |
EXP |
18 |
56,591,786 |
56,663,446 |
RGD:6480464 |
CTD |
| G |
Gramd4 |
GRAM domain containing 4 |
|
affects expression |
EXP |
15 |
85,888,137 |
85,968,064 |
RGD:6480464 |
CTD |
| G |
Grap |
GRB2-related adaptor protein |
|
multiple interactions |
ISO |
11 |
61,466,823 |
61,486,279 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
affects expression |
EXP |
2 |
64,750,535 |
64,860,823 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
increases expression |
EXP |
2 |
64,750,535 |
64,860,823 |
RGD:6480464 |
CTD |
| G |
Grb7 |
growth factor receptor bound protein 7 |
|
affects expression |
EXP |
11 |
98,308,148 |
98,316,687 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
affects expression |
EXP |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Grem1 |
gremlin 1 |
|
affects expression |
EXP |
2 |
113,588,832 |
113,598,805 |
RGD:6480464 |
CTD |
| G |
Grhl1 |
grainyhead-like 1 (Drosophila) |
|
increases expression |
ISO |
12 |
25,257,152 |
25,302,256 |
RGD:6480464 |
CTD |
| G |
Grhl1 |
grainyhead-like 1 (Drosophila) |
|
affects expression |
EXP |
12 |
25,257,152 |
25,302,256 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
decreases expression |
ISO |
11 |
56,825,193 |
57,143,746 |
RGD:6480464 |
CTD |
| G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
decreases expression |
ISO |
3 |
80,488,858 |
80,606,713 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
|
decreases expression |
EXP |
10 |
48,819,269 |
49,508,560 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
|
affects expression |
EXP |
7 |
25,794,868 |
25,857,388 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
|
decreases expression |
ISO |
2 |
25,146,697 |
25,174,683 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
|
increases expression |
ISO |
16 |
9,577,803 |
9,992,626 |
RGD:6480464 |
CTD |
| G |
H2-Ke6 |
H2-K region expressed gene 6 |
|
increases expression |
EXP |
17 |
34,162,978 |
34,165,000 |
RGD:6480464 |
CTD |
| G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
affects expression |
EXP |
17 |
37,407,179 |
37,411,430 |
RGD:6480464 |
CTD |
| G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
|
increases expression |
EXP |
4 |
149,353,590 |
149,383,132 |
RGD:6480464 |
CTD |
| G |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
|
multiple interactions |
ISO |
17 |
84,230,694 |
84,246,130 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
increases expression |
EXP |
14 |
32,420,412 |
32,454,151 |
RGD:6480464 |
CTD |
| G |
Hadhb |
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit |
|
affects expression |
EXP |
5 |
30,481,862 |
30,511,123 |
RGD:6480464 |
CTD |
| G |
Hadhb |
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit |
|
increases expression |
EXP |
5 |
30,481,862 |
30,511,123 |
RGD:6480464 |
CTD |
| G |
Hagh |
hydroxyacyl glutathione hydrolase |
|
increases expression |
EXP |
17 |
24,987,435 |
25,001,395 |
RGD:6480464 |
CTD |
| G |
Hand2 |
heart and neural crest derivatives expressed transcript 2 |
|
affects expression |
EXP |
8 |
59,799,780 |
59,803,314 |
RGD:6480464 |
CTD |
| G |
Hao3 |
hydroxyacid oxidase (glycolate oxidase) 3 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Hap1 |
huntingtin-associated protein 1 |
|
affects expression |
EXP |
11 |
100,208,641 |
100,217,455 |
RGD:6480464 |
CTD |
| G |
Hap1 |
huntingtin-associated protein 1 |
|
increases expression |
EXP |
11 |
100,208,641 |
100,217,455 |
RGD:6480464 |
CTD |
| G |
Hapln3 |
hyaluronan and proteoglycan link protein 3 |
|
affects expression |
EXP |
7 |
86,261,913 |
86,275,904 |
RGD:6480464 |
CTD |
| G |
Haus4 |
HAUS augmin-like complex, subunit 4 |
|
affects expression |
EXP |
14 |
55,160,622 |
55,173,198 |
RGD:6480464 |
CTD |
| G |
Haus7 |
HAUS augmin-like complex, subunit 7 |
|
affects expression |
EXP |
X |
70,682,654 |
70,704,368 |
RGD:6480464 |
CTD |
| G |
Hax1 |
HCLS1 associated X-1 |
|
decreases expression |
EXP |
3 |
89,799,379 |
89,802,608 |
RGD:6480464 |
CTD |
| G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
|
increases expression |
EXP |
11 |
32,183,672 |
32,184,486 |
RGD:6480464 |
CTD |
| G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
|
multiple interactions |
ISO |
11 |
32,196,492 |
32,197,310 |
RGD:6480464 |
CTD |
| G |
Hba-x |
hemoglobin X, alpha-like embryonic chain in Hba complex |
|
affects expression |
EXP |
11 |
32,176,600 |
32,178,116 |
RGD:6480464 |
CTD |
| G |
Hba-x |
hemoglobin X, alpha-like embryonic chain in Hba complex |
|
multiple interactions |
ISO |
11 |
32,176,600 |
32,178,116 |
RGD:6480464 |
CTD |
| G |
Hbb-bh1 |
hemoglobin Z, beta-like embryonic chain |
|
affects expression |
EXP |
7 |
110,990,152 |
110,991,676 |
RGD:6480464 |
CTD |
| G |
Hbp1 |
high mobility group box transcription factor 1 |
|
increases expression |
ISO |
12 |
32,611,320 |
32,635,400 |
RGD:6480464 |
CTD |
| G |
Hcfc1r1 |
host cell factor C1 regulator 1 (XPO1-dependent) |
|
multiple interactions |
ISO |
17 |
23,810,575 |
23,812,491 |
RGD:6480464 |
CTD |
| G |
Hcfc1r1 |
host cell factor C1 regulator 1 (XPO1-dependent) |
|
increases expression |
ISO |
17 |
23,810,575 |
23,812,491 |
RGD:6480464 |
CTD |
| G |
Hcfc2 |
host cell factor C2 |
|
increases expression |
EXP |
10 |
82,161,752 |
82,204,137 |
RGD:6480464 |
CTD |
| G |
Hcls1 |
hematopoietic cell specific Lyn substrate 1 |
|
affects expression |
EXP |
16 |
36,935,069 |
36,963,300 |
RGD:6480464 |
CTD |
| G |
Hcn3 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 3 |
|
increases expression |
EXP |
3 |
88,950,697 |
88,964,079 |
RGD:6480464 |
CTD |
| G |
Hcst |
hematopoietic cell signal transducer |
|
affects expression |
EXP |
7 |
31,202,731 |
31,204,873 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
decreases activity |
ISO |
4 |
129,193,348 |
129,219,890 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
multiple interactions |
ISO |
10 |
36,694,350 |
36,721,694 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
decreases activity |
ISO |
10 |
36,694,350 |
36,721,694 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
decreases expression |
ISO |
10 |
36,694,350 |
36,721,694 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
increases degradation |
ISO |
10 |
36,694,350 |
36,721,694 |
RGD:6480464 |
CTD |
| G |
Hdac3 |
histone deacetylase 3 |
|
decreases activity |
ISO |
18 |
38,096,625 |
38,114,642 |
RGD:6480464 |
CTD |
| G |
Hdac5 |
histone deacetylase 5 |
|
affects expression |
EXP |
11 |
102,057,061 |
102,091,486 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
decreases expression |
ISO |
3 |
87,710,243 |
87,720,054 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
affects expression |
EXP |
3 |
87,710,243 |
87,720,054 |
RGD:6480464 |
CTD |
| G |
Hdgfl1 |
hepatoma derived growth factor-like 1 |
|
multiple interactions |
ISO |
13 |
26,860,041 |
26,862,034 |
RGD:6480464 |
CTD |
| G |
Hdgfrp2 |
hepatoma-derived growth factor, related protein 2 |
|
affects expression |
EXP |
17 |
56,219,080 |
56,240,019 |
RGD:6480464 |
CTD |
| G |
Heatr2 |
HEAT repeat containing 2 |
|
multiple interactions |
ISO |
5 |
139,626,177 |
139,662,459 |
RGD:6480464 |
CTD |
| G |
Heatr5b |
HEAT repeat containing 5B |
|
multiple interactions |
ISO |
17 |
79,152,246 |
79,234,721 |
RGD:6480464 |
CTD |
| G |
Hebp1 |
heme binding protein 1 |
|
multiple interactions |
ISO |
6 |
135,087,537 |
135,118,233 |
RGD:6480464 |
CTD |
| G |
Hebp1 |
heme binding protein 1 |
|
increases expression |
EXP |
6 |
135,087,537 |
135,118,233 |
RGD:6480464 |
CTD |
| G |
Hebp1 |
heme binding protein 1 |
|
increases expression |
ISO |
6 |
135,087,537 |
135,118,233 |
RGD:6480464 |
CTD |
| G |
Hebp2 |
heme binding protein 2 |
|
increases expression |
ISO |
10 |
18,259,929 |
18,265,882 |
RGD:6480464 |
CTD |
| G |
Heca |
headcase homolog (Drosophila) |
|
increases expression |
ISO |
10 |
17,620,272 |
17,667,873 |
RGD:6480464 |
CTD |
| G |
Hectd3 |
HECT domain containing 3 |
|
increases expression |
ISO |
4 |
116,667,953 |
116,677,882 |
RGD:6480464 |
CTD |
| G |
Hectd3 |
HECT domain containing 3 |
|
affects expression |
EXP |
4 |
116,667,953 |
116,677,882 |
RGD:6480464 |
CTD |
| G |
Heg1 |
HEG homolog 1 (zebrafish) |
|
affects expression |
EXP |
16 |
33,684,552 |
33,768,281 |
RGD:6480464 |
CTD |
| G |
Hemgn |
hemogen |
|
affects expression |
EXP |
4 |
46,406,861 |
46,417,055 |
RGD:6480464 |
CTD |
| G |
Henmt1 |
HEN1 methyltransferase homolog 1 (Arabidopsis) |
|
multiple interactions |
ISO |
3 |
108,743,002 |
108,763,694 |
RGD:6480464 |
CTD |
| G |
Herpud1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
affects expression |
EXP |
8 |
96,910,400 |
96,919,258 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
increases expression |
ISO |
13 |
97,946,286 |
97,968,312 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
affects expression |
EXP |
13 |
97,946,286 |
97,968,312 |
RGD:6480464 |
CTD |
| G |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
|
affects expression |
EXP |
11 |
102,994,653 |
103,001,222 |
RGD:6480464 |
CTD |
| G |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
|
increases expression |
EXP |
10 |
30,552,165 |
30,562,589 |
RGD:6480464 |
CTD |
| G |
Hfe |
hemochromatosis |
|
multiple interactions |
ISO |
13 |
23,795,710 |
23,802,680 |
RGD:6480464 |
CTD |
| G |
Hgd |
homogentisate 1, 2-dioxygenase |
|
affects expression |
EXP |
16 |
37,580,239 |
37,632,112 |
RGD:6480464 |
CTD |
| G |
Hhex |
hematopoietically expressed homeobox |
|
affects expression |
EXP |
19 |
37,509,331 |
37,515,221 |
RGD:6480464 |
CTD |
| G |
Hic2 |
hypermethylated in cancer 2 |
|
affects expression |
EXP |
16 |
17,233,680 |
17,263,523 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases activity |
ISO |
3 |
98,656,120 |
98,663,717 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases expression |
ISO |
3 |
98,656,120 |
98,663,717 |
RGD:6480464 |
CTD |
| G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
affects expression |
EXP |
7 |
134,944,123 |
134,947,316 |
RGD:6480464 |
CTD |
| G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
decreases expression |
EXP |
7 |
134,944,123 |
134,947,316 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
affects expression |
EXP |
4 |
59,594,435 |
59,631,566 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
decreases expression |
EXP |
4 |
59,594,435 |
59,631,566 |
RGD:6480464 |
CTD |
| G |
Hsdl2 |
hydroxysteroid dehydrogenase like 2 |
|
increases expression |
EXP |
4 |
59,594,435 |
59,631,566 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
decreases expression |
EXP |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
affects expression |
EXP |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
affects expression |
EXP |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
ISO |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
affects expression |
EXP |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
multiple interactions |
EXP |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
increases expression |
ISO |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
EXP |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
decreases expression |
EXP |
12 |
77,505,163 |
77,507,925 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
increases expression |
EXP |
12 |
77,505,163 |
77,507,925 |
RGD:6480464 |
CTD |
| G |
Hspa4l |
heat shock protein 4 like |
|
affects expression |
EXP |
3 |
40,549,535 |
40,594,287 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
affects expression |
EXP |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock protein 8 |
|
multiple interactions |
ISO |
9 |
40,609,356 |
40,613,282 |
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
multiple interactions |
ISO |
18 |
35,097,068 |
35,114,005 |
RGD:6480464 |
CTD |
| G |
Hspb11 |
heat shock protein family B (small), member 11 |
|
increases expression |
EXP |
4 |
106,926,539 |
106,952,493 |
RGD:6480464 |
CTD |
| G |
Hspb2 |
heat shock protein 2 |
|
affects expression |
EXP |
9 |
50,559,177 |
50,560,459 |
RGD:6480464 |
CTD |
| G |
Hspb6 |
heat shock protein, alpha-crystallin-related, B6 |
|
affects expression |
EXP |
7 |
31,338,321 |
31,340,458 |
RGD:6480464 |
CTD |
| G |
Hspbp1 |
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
|
affects expression |
EXP |
7 |
4,612,123 |
4,636,565 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
EXP |
1 |
55,134,678 |
55,144,776 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
|
affects expression |
EXP |
5 |
150,419,420 |
150,438,890 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 tat interactive protein 2, homolog (human) |
|
affects expression |
EXP |
7 |
57,014,476 |
57,029,369 |
RGD:6480464 |
CTD |
| G |
Htr1b |
5-hydroxytryptamine (serotonin) receptor 1B |
|
affects expression |
EXP |
9 |
81,524,999 |
81,526,159 |
RGD:6480464 |
CTD |
| G |
Htr3b |
5-hydroxytryptamine (serotonin) receptor 3B |
|
affects expression |
EXP |
9 |
48,743,113 |
48,773,095 |
RGD:6480464 |
CTD |
| G |
Htr4 |
5 hydroxytryptamine (serotonin) receptor 4 |
|
increases expression |
ISO |
18 |
62,483,858 |
62,627,456 |
RGD:6480464 |
CTD |
| G |
Htr4 |
5 hydroxytryptamine (serotonin) receptor 4 |
|
affects expression |
EXP |
18 |
62,483,858 |
62,627,456 |
RGD:6480464 |
CTD |
| G |
Htr5b |
5-hydroxytryptamine (serotonin) receptor 5B |
|
affects expression |
EXP |
1 |
123,406,335 |
123,425,042 |
RGD:6480464 |
CTD |
| G |
Htra3 |
HtrA serine peptidase 3 |
|
affects expression |
EXP |
5 |
35,994,682 |
36,022,431 |
RGD:6480464 |
CTD |
| G |
Hunk |
hormonally upregulated Neu-associated kinase |
|
affects expression |
EXP |
16 |
90,386,642 |
90,499,798 |
RGD:6480464 |
CTD |
| G |
Hvcn1 |
hydrogen voltage-gated channel 1 |
|
increases expression |
EXP |
5 |
122,659,746 |
122,692,306 |
RGD:6480464 |
CTD |
| G |
Hyal1 |
hyaluronoglucosaminidase 1 |
|
affects expression |
EXP |
9 |
107,479,283 |
107,482,468 |
RGD:6480464 |
CTD |
| G |
Hyal3 |
hyaluronoglucosaminidase 3 |
|
affects expression |
EXP |
9 |
107,483,627 |
107,489,690 |
RGD:6480464 |
CTD |
| G |
Hydin |
HYDIN, axonemal central pair apparatus protein |
|
affects expression |
EXP |
8 |
112,790,877 |
113,134,153 |
RGD:6480464 |
CTD |
| G |
Hyi |
hydroxypyruvate isomerase homolog (E. coli) |
|
multiple interactions |
ISO |
4 |
118,032,619 |
118,035,349 |
RGD:6480464 |
CTD |
| G |
Ica1l |
islet cell autoantigen 1-like |
|
affects expression |
EXP |
1 |
60,045,912 |
60,099,931 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Icmt |
isoprenylcysteine carboxyl methyltransferase |
|
multiple interactions |
ISO |
4 |
151,671,460 |
151,681,231 |
RGD:6480464 |
CTD |
| G |
Icmt |
isoprenylcysteine carboxyl methyltransferase |
|
increases expression |
EXP |
4 |
151,671,460 |
151,681,231 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
increases expression |
EXP |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
affects expression |
EXP |
12 |
25,778,664 |
25,780,957 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
EXP |
12 |
25,778,664 |
25,780,957 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
decreases expression |
ISO |
7 |
87,239,732 |
87,260,236 |
RGD:6480464 |
CTD |
| G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
|
affects expression |
EXP |
9 |
54,434,318 |
54,452,469 |
RGD:6480464 |
CTD |
| G |
Idh3g |
isocitrate dehydrogenase 3 (NAD+), gamma |
|
multiple interactions |
ISO |
X |
71,024,302 |
71,032,236 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase |
|
affects expression |
EXP |
13 |
8,884,852 |
8,891,642 |
RGD:6480464 |
CTD |
| G |
Idi2 |
isopentenyl-diphosphate delta isomerase 2 |
|
affects expression |
EXP |
13 |
8,952,109 |
8,960,181 |
RGD:6480464 |
CTD |
| G |
Ids |
iduronate 2-sulfatase |
|
affects expression |
EXP |
X |
67,596,244 |
67,618,260 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
affects expression |
EXP |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
EXP |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier5 |
immediate early response 5 |
|
increases expression |
EXP |
1 |
156,943,497 |
156,946,766 |
RGD:6480464 |
CTD |
| G |
Iffo2 |
intermediate filament family orphan 2 |
|
affects expression |
EXP |
4 |
139,131,051 |
139,176,297 |
RGD:6480464 |
CTD |
| G |
Ifi204 |
interferon activated gene 204 |
|
affects expression |
EXP |
1 |
175,677,424 |
175,697,050 |
RGD:6480464 |
CTD |
| G |
Ifi30 |
interferon gamma inducible protein 30 |
|
increases expression |
EXP |
8 |
73,286,672 |
73,290,562 |
RGD:6480464 |
CTD |
| G |
Ifi30 |
interferon gamma inducible protein 30 |
|
increases expression |
ISO |
8 |
73,286,672 |
73,290,562 |
RGD:6480464 |
CTD |
| G |
Impdh2 |
inosine 5'-phosphate dehydrogenase 2 |
|
affects expression |
EXP |
9 |
108,462,832 |
108,467,904 |
RGD:6480464 |
CTD |
| G |
Inca1 |
inhibitor of CDK, cyclin A1 interacting protein 1 |
|
affects expression |
EXP |
11 |
70,501,863 |
70,513,657 |
RGD:6480464 |
CTD |
| G |
Ing1 |
inhibitor of growth family, member 1 |
|
affects expression |
EXP |
8 |
11,556,066 |
11,563,250 |
RGD:6480464 |
CTD |
| G |
Ing3 |
inhibitor of growth family, member 3 |
|
affects expression |
EXP |
6 |
21,899,615 |
21,926,037 |
RGD:6480464 |
CTD |
| G |
Ing4 |
inhibitor of growth family, member 4 |
|
affects expression |
EXP |
6 |
124,989,866 |
124,999,282 |
RGD:6480464 |
CTD |
| G |
Ing5 |
inhibitor of growth family, member 5 |
|
decreases expression |
EXP |
1 |
95,700,542 |
95,718,678 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
multiple interactions |
ISO |
1 |
75,503,652 |
75,506,929 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
increases expression |
ISO |
13 |
16,106,308 |
16,119,044 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
affects expression |
EXP |
10 |
126,786,458 |
126,788,828 |
RGD:6480464 |
CTD |
| G |
Inmt |
indolethylamine N-methyltransferase |
|
affects expression |
EXP |
6 |
55,120,621 |
55,124,984 |
RGD:6480464 |
CTD |
| G |
Ino80c |
INO80 complex subunit C |
|
affects expression |
EXP |
18 |
24,263,262 |
24,280,320 |
RGD:6480464 |
CTD |
| G |
Ino80e |
INO80 complex subunit E |
|
multiple interactions |
ISO |
7 |
133,995,947 |
134,004,977 |
RGD:6480464 |
CTD |
| G |
Ino80e |
INO80 complex subunit E |
|
affects expression |
EXP |
7 |
133,995,947 |
134,004,977 |
RGD:6480464 |
CTD |
| G |
Inpp1 |
inositol polyphosphate-1-phosphatase |
|
affects expression |
EXP |
1 |
52,846,262 |
52,874,532 |
RGD:6480464 |
CTD |
| G |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
|
affects expression |
EXP |
7 |
146,575,008 |
146,765,551 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin I |
|
affects expression |
EXP |
19 |
52,338,813 |
52,339,966 |
RGD:6480464 |
CTD |
| G |
Insc |
inscuteable homolog (Drosophila) |
|
affects expression |
EXP |
7 |
121,889,280 |
121,993,894 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
affects expression |
EXP |
5 |
28,397,952 |
28,405,202 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
affects expression |
EXP |
1 |
123,200,930 |
123,229,157 |
RGD:6480464 |
CTD |
| G |
Insl6 |
insulin-like 6 |
|
increases expression |
EXP |
19 |
29,395,844 |
29,399,808 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
affects expression |
EXP |
8 |
3,150,922 |
3,279,617 |
RGD:6480464 |
CTD |
| G |
Insrr |
insulin receptor-related receptor |
|
affects expression |
EXP |
3 |
87,600,873 |
87,620,023 |
RGD:6480464 |
CTD |
| G |
Ints12 |
integrator complex subunit 12 |
|
decreases expression |
EXP |
3 |
132,754,917 |
132,773,952 |
RGD:6480464 |
CTD |
| G |
Ints2 |
integrator complex subunit 2 |
|
affects expression |
EXP |
11 |
86,024,185 |
86,071,070 |
RGD:6480464 |
CTD |
| G |
Ints2 |
integrator complex subunit 2 |
|
decreases expression |
EXP |
11 |
86,024,185 |
86,071,070 |
RGD:6480464 |
CTD |
| G |
Ints9 |
integrator complex subunit 9 |
|
affects expression |
EXP |
14 |
65,568,882 |
65,658,663 |
RGD:6480464 |
CTD |
| G |
Intu |
inturned planar cell polarity effector homolog (Drosophila) |
|
increases expression |
EXP |
3 |
40,457,623 |
40,508,662 |
RGD:6480464 |
CTD |
| G |
Ip6k1 |
inositol hexaphosphate kinase 1 |
|
decreases expression |
EXP |
9 |
107,904,979 |
107,951,113 |
RGD:6480464 |
CTD |
| G |
Ipo13 |
importin 13 |
|
affects expression |
EXP |
4 |
117,567,098 |
117,587,604 |
RGD:6480464 |
CTD |
| G |
Ipo4 |
importin 4 |
|
affects expression |
EXP |
14 |
56,244,466 |
56,254,515 |
RGD:6480464 |
CTD |
| G |
Ipo4 |
importin 4 |
|
decreases expression |
ISO |
14 |
56,244,466 |
56,254,515 |
RGD:6480464 |
CTD |
| G |
Ipo7 |
importin 7 |
|
affects expression |
EXP |
7 |
117,161,939 |
117,198,628 |
RGD:6480464 |
CTD |
| G |
Ipo8 |
importin 8 |
|
affects expression |
EXP |
6 |
148,719,206 |
148,779,989 |
RGD:6480464 |
CTD |
| G |
Ippk |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
|
affects expression |
EXP |
13 |
49,516,680 |
49,558,359 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
decreases expression |
ISO |
X |
71,259,253 |
71,269,260 |
RGD:6480464 |
CTD |
| G |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
|
affects expression |
EXP |
6 |
113,588,461 |
113,645,020 |
RGD:6480464 |
CTD |
| G |
Irf5 |
interferon regulatory factor 5 |
|
affects expression |
EXP |
6 |
29,476,733 |
29,487,319 |
RGD:6480464 |
CTD |
| G |
Irf6 |
interferon regulatory factor 6 |
|
increases expression |
EXP |
1 |
194,979,306 |
194,998,230 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
multiple interactions |
ISO |
7 |
148,449,088 |
148,452,300 |
RGD:6480464 |
CTD |
| G |
Irgc1 |
immunity-related GTPase family, cinema 1 |
|
affects expression |
EXP |
7 |
25,216,945 |
25,230,701 |
RGD:6480464 |
CTD |
| G |
Irgm1 |
immunity-related GTPase family M member 1 |
|
affects expression |
EXP |
11 |
48,678,751 |
48,684,848 |
RGD:6480464 |
CTD |
| G |
Irs3 |
insulin receptor substrate 3 |
|
affects expression |
EXP |
5 |
138,084,260 |
138,086,942 |
RGD:6480464 |
CTD |
| G |
Irx3 |
Iroquois related homeobox 3 (Drosophila) |
|
multiple interactions |
ISO |
8 |
94,322,424 |
94,325,273 |
RGD:6480464 |
CTD |
| G |
Isca2 |
iron-sulfur cluster assembly 2 homolog (S. cerevisiae) |
|
increases expression |
ISO |
12 |
86,114,220 |
86,116,039 |
RGD:6480464 |
CTD |
| G |
Iscu |
IscU iron-sulfur cluster scaffold homolog (E. coli) |
|
affects expression |
EXP |
5 |
114,222,821 |
114,228,291 |
RGD:6480464 |
CTD |
| G |
Isl1 |
ISL1 transcription factor, LIM/homeodomain |
|
affects expression |
EXP |
13 |
117,088,478 |
117,099,896 |
RGD:6480464 |
CTD |
| G |
Isyna1 |
myo-inositol 1-phosphate synthase A1 |
|
increases expression |
ISO |
8 |
73,118,380 |
73,121,189 |
RGD:6480464 |
CTD |
| G |
Itfg2 |
integrin alpha FG-GAP repeat containing 2 |
|
decreases expression |
EXP |
6 |
128,359,462 |
128,374,928 |
RGD:6480464 |
CTD |
| G |
Itga2 |
integrin alpha 2 |
|
increases expression |
ISO |
13 |
115,626,120 |
115,722,249 |
RGD:6480464 |
CTD |
| G |
Itga9 |
integrin alpha 9 |
|
affects expression |
EXP |
9 |
118,515,827 |
118,810,121 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin alpha M |
|
multiple interactions |
ISO |
7 |
135,206,154 |
135,262,005 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin alpha M |
|
affects expression |
EXP |
7 |
135,206,154 |
135,262,005 |
RGD:6480464 |
CTD |
| G |
Itih5 |
inter-alpha (globulin) inhibitor H5 |
|
increases expression |
EXP |
2 |
10,075,170 |
10,178,156 |
RGD:6480464 |
CTD |
| G |
Itpa |
inosine triphosphatase (nucleoside triphosphate pyrophosphatase) |
|
affects expression |
EXP |
2 |
130,493,577 |
130,507,350 |
RGD:6480464 |
CTD |
| G |
Itpk1 |
inositol 1,3,4-triphosphate 5/6 kinase |
|
increases expression |
EXP |
12 |
103,806,793 |
103,943,079 |
RGD:6480464 |
CTD |
| G |
Itpka |
inositol 1,4,5-trisphosphate 3-kinase A |
|
increases expression |
EXP |
2 |
119,568,073 |
119,576,989 |
RGD:6480464 |
CTD |
| G |
Itpr3 |
inositol 1,4,5-triphosphate receptor 3 |
|
increases expression |
ISO |
17 |
27,194,249 |
27,259,168 |
RGD:6480464 |
CTD |
| G |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
|
multiple interactions |
ISO |
16 |
91,729,616 |
91,920,824 |
RGD:6480464 |
CTD |
| G |
Itsn2 |
intersectin 2 |
|
multiple interactions |
ISO |
12 |
4,599,814 |
4,720,758 |
RGD:6480464 |
CTD |
| G |
Ivd |
isovaleryl coenzyme A dehydrogenase |
|
decreases expression |
EXP |
2 |
118,687,736 |
118,707,093 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
affects expression |
EXP |
3 |
92,374,824 |
92,377,637 |
RGD:6480464 |
CTD |
| G |
Ivns1abp |
influenza virus NS1A binding protein |
|
decreases expression |
ISO |
1 |
153,191,628 |
153,211,575 |
RGD:6480464 |
CTD |
| G |
Iyd |
iodotyrosine deiodinase |
|
affects expression |
EXP |
10 |
6,791,664 |
6,806,262 |
RGD:6480464 |
CTD |
| G |
Kif19a |
kinesin family member 19A |
|
affects expression |
EXP |
11 |
114,626,703 |
114,651,889 |
RGD:6480464 |
CTD |
| G |
Kif1a |
kinesin family member 1A |
|
affects expression |
EXP |
1 |
94,912,033 |
94,998,442 |
RGD:6480464 |
CTD |
| G |
Kif20b |
kinesin family member 20B |
|
decreases expression |
ISO |
19 |
34,996,848 |
35,050,221 |
RGD:6480464 |
CTD |
| G |
Kif21b |
kinesin family member 21B |
|
increases expression |
ISO |
1 |
138,027,978 |
138,074,591 |
RGD:6480464 |
CTD |
| G |
Kif2c |
kinesin family member 2C |
|
decreases expression |
EXP |
4 |
116,832,239 |
116,855,229 |
RGD:6480464 |
CTD |
| G |
Kif3c |
kinesin family member 3C |
|
affects expression |
EXP |
12 |
3,365,132 |
3,406,494 |
RGD:6480464 |
CTD |
| G |
Kif5c |
kinesin family member 5C |
|
increases expression |
ISO |
2 |
49,474,834 |
49,630,298 |
RGD:6480464 |
CTD |
| G |
Kif9 |
kinesin family member 9 |
|
affects expression |
EXP |
9 |
110,379,462 |
110,427,678 |
RGD:6480464 |
CTD |
| G |
Kif9 |
kinesin family member 9 |
|
increases expression |
EXP |
9 |
110,379,462 |
110,427,678 |
RGD:6480464 |
CTD |
| G |
Kifc2 |
kinesin family member C2 |
|
affects expression |
EXP |
15 |
76,491,071 |
76,498,626 |
RGD:6480464 |
CTD |
| G |
Kifc2 |
kinesin family member C2 |
|
increases expression |
ISO |
15 |
76,491,071 |
76,498,626 |
RGD:6480464 |
CTD |
| G |
Kirrel2 |
kin of IRRE like 2 (Drosophila) |
|
affects expression |
EXP |
7 |
31,232,785 |
31,242,534 |
RGD:6480464 |
CTD |
| G |
Kit |
kit oncogene |
|
increases expression |
ISO |
5 |
75,971,012 |
76,052,747 |
RGD:6480464 |
CTD |
| G |
Kitl |
kit ligand |
|
affects expression |
EXP |
10 |
99,478,458 |
99,563,046 |
RGD:6480464 |
CTD |
| G |
Kitl |
kit ligand |
|
increases expression |
ISO |
10 |
99,478,458 |
99,563,046 |
RGD:6480464 |
CTD |
| G |
Klf13 |
Kruppel-like factor 13 |
|
affects expression |
EXP |
7 |
71,031,237 |
71,083,801 |
RGD:6480464 |
CTD |
| G |
Klf3 |
Kruppel-like factor 3 (basic) |
|
decreases expression |
EXP |
5 |
65,194,762 |
65,221,368 |
RGD:6480464 |
CTD |
| G |
Klf5 |
Kruppel-like factor 5 |
|
increases expression |
EXP |
14 |
99,697,910 |
99,712,631 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
multiple interactions |
ISO |
13 |
5,860,735 |
5,869,639 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
ISO |
19 |
23,215,716 |
23,241,401 |
RGD:6480464 |
CTD |
| G |
Klhdc4 |
kelch domain containing 4 |
|
affects expression |
EXP |
8 |
124,320,208 |
124,353,469 |
RGD:6480464 |
CTD |
| G |
Klhdc7a |
kelch domain containing 7A |
|
affects expression |
EXP |
4 |
139,518,088 |
139,523,941 |
RGD:6480464 |
CTD |
| G |
Klhdc8b |
kelch domain containing 8B |
|
increases expression |
EXP |
9 |
108,349,970 |
108,363,912 |
RGD:6480464 |
CTD |
| G |
Klhl11 |
kelch-like 11 |
|
affects expression |
EXP |
11 |
100,323,926 |
100,334,096 |
RGD:6480464 |
CTD |
| G |
Klhl13 |
kelch-like 13 |
|
affects expression |
EXP |
X |
22,796,397 |
22,942,179 |
RGD:6480464 |
CTD |
| G |
Klhl23 |
kelch-like 23 |
|
affects expression |
EXP |
2 |
69,660,427 |
69,674,708 |
RGD:6480464 |
CTD |
| G |
Klhl23 |
kelch-like 23 |
|
multiple interactions |
ISO |
2 |
69,660,427 |
69,674,708 |
RGD:6480464 |
CTD |
| G |
Klhl26 |
kelch-like 26 |
|
increases expression |
EXP |
8 |
72,974,127 |
73,000,842 |
RGD:6480464 |
CTD |
| G |
Klhl26 |
kelch-like 26 |
|
increases expression |
ISO |
8 |
72,974,127 |
73,000,842 |
RGD:6480464 |
CTD |
| G |
Klhl29 |
kelch-like 29 |
|
increases expression |
ISO |
12 |
5,084,271 |
5,382,488 |
RGD:6480464 |
CTD |
| G |
Klhl29 |
kelch-like 29 |
|
affects expression |
EXP |
12 |
5,084,271 |
5,382,488 |
RGD:6480464 |
CTD |
| G |
Klhl42 |
kelch-like 42 |
|
decreases expression |
ISO |
6 |
147,039,597 |
147,061,300 |
RGD:6480464 |
CTD |
| G |
Klhl5 |
kelch-like 5 |
|
increases expression |
ISO |
5 |
65,522,470 |
65,559,381 |
RGD:6480464 |
CTD |
| G |
Klhl5 |
kelch-like 5 |
|
increases expression |
EXP |
5 |
65,522,470 |
65,559,381 |
RGD:6480464 |
CTD |
| G |
Klhl8 |
kelch-like 8 |
|
increases expression |
ISO |
5 |
104,291,069 |
104,340,248 |
RGD:6480464 |
CTD |
| G |
Klhl9 |
kelch-like 9 |
|
multiple interactions |
ISO |
4 |
88,364,196 |
88,368,412 |
RGD:6480464 |
CTD |
| G |
Klk1b1 |
kallikrein 1-related peptidase b1 |
|
affects expression |
EXP |
7 |
51,222,138 |
51,226,686 |
RGD:6480464 |
CTD |
| G |
Klk1b21 |
kallikrein 1-related peptidase b21 |
|
affects expression |
EXP |
7 |
51,357,662 |
51,361,950 |
RGD:6480464 |
CTD |
| G |
Klk9 |
kallikrein related-peptidase 9 |
|
affects expression |
EXP |
7 |
51,047,261 |
51,052,126 |
RGD:6480464 |
CTD |
| G |
Klra2 |
killer cell lectin-like receptor, subfamily A, member 2 |
|
affects expression |
EXP |
6 |
131,169,253 |
131,197,380 |
RGD:6480464 |
CTD |
| G |
Klrg2 |
killer cell lectin-like receptor subfamily G, member 2 |
|
increases expression |
EXP |
6 |
38,576,660 |
38,587,239 |
RGD:6480464 |
CTD |
| G |
Kntc1 |
kinetochore associated 1 |
|
affects expression |
EXP |
5 |
124,199,735 |
124,271,602 |
RGD:6480464 |
CTD |
| G |
Kpna1 |
karyopherin (importin) alpha 1 |
|
decreases expression |
EXP |
16 |
35,983,449 |
36,036,248 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin (importin) alpha 2 |
|
affects expression |
EXP |
11 |
106,849,943 |
106,860,839 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
decreases expression |
ISO |
11 |
97,021,024 |
97,049,206 |
RGD:6480464 |
CTD |
| G |
Kremen2 |
kringle containing transmembrane protein 2 |
|
increases expression |
EXP |
17 |
23,878,166 |
23,882,796 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
multiple interactions |
ISO |
11 |
100,117,531 |
100,122,303 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
EXP |
15 |
101,858,647 |
101,862,457 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
affects expression |
EXP |
15 |
101,858,647 |
101,862,457 |
RGD:6480464 |
CTD |
| G |
Krt23 |
keratin 23 |
|
affects expression |
EXP |
11 |
99,339,287 |
99,354,424 |
RGD:6480464 |
CTD |
| G |
Krt24 |
keratin 24 |
|
affects expression |
EXP |
11 |
99,141,407 |
99,146,552 |
RGD:6480464 |
CTD |
| G |
Krt33a |
keratin 33A |
|
affects expression |
EXP |
11 |
99,872,513 |
99,877,526 |
RGD:6480464 |
CTD |
| G |
Krt6b |
keratin 6B |
|
affects expression |
EXP |
15 |
101,506,454 |
101,510,720 |
RGD:6480464 |
CTD |
| G |
Krt7 |
keratin 7 |
|
affects expression |
EXP |
15 |
101,242,834 |
101,258,237 |
RGD:6480464 |
CTD |
| G |
Krt84 |
keratin 84 |
|
affects expression |
EXP |
15 |
101,355,457 |
101,363,251 |
RGD:6480464 |
CTD |
| G |
Krtap14 |
keratin associated protein 14 |
|
affects expression |
EXP |
16 |
88,825,536 |
88,826,390 |
RGD:6480464 |
CTD |
| G |
Krtap19-5 |
keratin associated protein 19-5 |
|
affects expression |
EXP |
16 |
88,896,213 |
88,896,694 |
RGD:6480464 |
CTD |
| G |
Krtap5-5 |
keratin associated protein 5-5 |
|
affects expression |
EXP |
7 |
149,414,700 |
149,415,876 |
RGD:6480464 |
CTD |
| G |
Kti12 |
KTI12 homolog, chromatin associated (S. cerevisiae) |
|
affects expression |
EXP |
4 |
108,520,462 |
108,522,017 |
RGD:6480464 |
CTD |
| G |
Kynu |
kynureninase (L-kynurenine hydrolase) |
|
affects expression |
EXP |
2 |
43,410,849 |
43,538,235 |
RGD:6480464 |
CTD |
| G |
Lactb |
lactamase, beta |
|
increases expression |
ISO |
9 |
66,803,200 |
66,823,291 |
RGD:6480464 |
CTD |
| G |
Lactb |
lactamase, beta |
|
increases expression |
EXP |
9 |
66,803,200 |
66,823,291 |
RGD:6480464 |
CTD |
| G |
Lage3 |
L antigen family, member 3 |
|
affects expression |
EXP |
X |
71,597,501 |
71,598,957 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
increases expression |
ISO |
16 |
19,653,474 |
19,706,458 |
RGD:6480464 |
CTD |
| G |
Lancl1 |
LanC (bacterial lantibiotic synthetase component C)-like 1 |
|
affects expression |
EXP |
1 |
67,047,091 |
67,085,439 |
RGD:6480464 |
CTD |
| G |
Lpin1 |
lipin 1 |
|
increases expression |
EXP |
12 |
16,542,475 |
16,596,576 |
RGD:6480464 |
CTD |
| G |
Lpin3 |
lipin 3 |
|
multiple interactions |
ISO |
2 |
160,706,469 |
160,731,528 |
RGD:6480464 |
CTD |
| G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
|
multiple interactions |
ISO |
16 |
24,393,436 |
24,992,664 |
RGD:6480464 |
CTD |
| G |
Lpxn |
leupaxin |
|
affects expression |
EXP |
19 |
12,873,099 |
12,908,298 |
RGD:6480464 |
CTD |
| G |
Lrat |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) |
|
affects expression |
EXP |
3 |
82,696,504 |
82,707,896 |
RGD:6480464 |
CTD |
| G |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
|
increases expression |
ISO |
X |
143,906,237 |
143,988,624 |
RGD:6480464 |
CTD |
| G |
Lrfn1 |
leucine rich repeat and fibronectin type III domain containing 1 |
|
multiple interactions |
ISO |
7 |
29,237,004 |
29,252,567 |
RGD:6480464 |
CTD |
| G |
Lrfn3 |
leucine rich repeat and fibronectin type III domain containing 3 |
|
affects expression |
EXP |
7 |
31,140,533 |
31,147,791 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
increases expression |
ISO |
6 |
94,554,523 |
94,650,139 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
affects expression |
EXP |
6 |
94,554,523 |
94,650,139 |
RGD:6480464 |
CTD |
| G |
Lrmp |
lymphoid-restricted membrane protein |
|
affects expression |
EXP |
6 |
145,070,259 |
145,123,448 |
RGD:6480464 |
CTD |
| G |
Lrp10 |
low-density lipoprotein receptor-related protein 10 |
|
multiple interactions |
ISO |
14 |
55,082,984 |
55,089,129 |
RGD:6480464 |
CTD |
| G |
Lrp10 |
low-density lipoprotein receptor-related protein 10 |
|
increases expression |
ISO |
14 |
55,082,984 |
55,089,129 |
RGD:6480464 |
CTD |
| G |
Lrp12 |
low density lipoprotein-related protein 12 |
|
affects expression |
EXP |
15 |
39,702,149 |
39,775,303 |
RGD:6480464 |
CTD |
| G |
Lrp3 |
low density lipoprotein receptor-related protein 3 |
|
affects expression |
EXP |
7 |
35,985,953 |
36,000,364 |
RGD:6480464 |
CTD |
| G |
Lrpprc |
leucine-rich PPR-motif containing |
|
affects expression |
EXP |
17 |
85,104,587 |
85,190,126 |
RGD:6480464 |
CTD |
| G |
Lrr1 |
leucine rich repeat protein 1 |
|
increases expression |
EXP |
12 |
70,269,801 |
70,279,997 |
RGD:6480464 |
CTD |
| G |
Lrrc16a |
leucine rich repeat containing 16A |
|
affects expression |
EXP |
13 |
24,104,353 |
24,372,659 |
RGD:6480464 |
CTD |
| G |
Lrrc2 |
leucine rich repeat containing 2 |
|
decreases expression |
EXP |
9 |
110,854,049 |
110,886,570 |
RGD:6480464 |
CTD |
| G |
Lrrc26 |
leucine rich repeat containing 26 |
|
affects expression |
EXP |
2 |
25,145,431 |
25,146,713 |
RGD:6480464 |
CTD |
| G |
Lrrc28 |
leucine rich repeat containing 28 |
|
affects expression |
EXP |
7 |
74,658,296 |
74,790,122 |
RGD:6480464 |
CTD |
| G |
Lrrc34 |
leucine rich repeat containing 34 |
|
increases expression |
EXP |
3 |
30,523,189 |
30,546,740 |
RGD:6480464 |
CTD |
| G |
Lrrc34 |
leucine rich repeat containing 34 |
|
decreases expression |
EXP |
3 |
30,523,189 |
30,546,740 |
RGD:6480464 |
CTD |
| G |
Lrrc40 |
leucine rich repeat containing 40 |
|
multiple interactions |
ISO |
3 |
157,699,667 |
157,731,442 |
RGD:6480464 |
CTD |
| G |
Lrrc41 |
leucine rich repeat containing 41 |
|
affects expression |
EXP |
4 |
115,748,070 |
115,769,648 |
RGD:6480464 |
CTD |
| G |
Lrrc59 |
leucine rich repeat containing 59 |
|
affects expression |
EXP |
11 |
94,491,138 |
94,506,530 |
RGD:6480464 |
CTD |
| G |
Lrrc8d |
leucine rich repeat containing 8D |
|
affects expression |
EXP |
5 |
106,128,988 |
106,244,234 |
RGD:6480464 |
CTD |
| G |
Lrrc8e |
leucine rich repeat containing 8 family, member E |
|
multiple interactions |
ISO |
8 |
4,226,827 |
4,237,470 |
RGD:6480464 |
CTD |
| G |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
|
increases expression |
EXP |
6 |
107,479,779 |
107,520,204 |
RGD:6480464 |
CTD |
| G |
Lrrtm2 |
leucine rich repeat transmembrane neuronal 2 |
|
affects expression |
EXP |
18 |
35,368,657 |
35,374,678 |
RGD:6480464 |
CTD |
| G |
Lrrtm4 |
leucine rich repeat transmembrane neuronal 4 |
|
affects expression |
EXP |
6 |
79,968,871 |
79,974,926 |
RGD:6480464 |
CTD |
| G |
Lrsam1 |
leucine rich repeat and sterile alpha motif containing 1 |
|
affects expression |
EXP |
2 |
32,780,740 |
32,816,771 |
RGD:6480464 |
CTD |
| G |
Lsamp |
limbic system-associated membrane protein |
|
affects expression |
EXP |
16 |
41,533,455 |
42,146,326 |
RGD:6480464 |
CTD |
| G |
Lsg1 |
large subunit GTPase 1 homolog (S. cerevisiae) |
|
affects expression |
EXP |
16 |
30,561,455 |
30,587,675 |
RGD:6480464 |
CTD |
| G |
Lsm10 |
U7 snRNP-specific Sm-like protein LSM10 |
|
affects expression |
EXP |
4 |
125,773,897 |
125,775,828 |
RGD:6480464 |
CTD |
| G |
Lsm12 |
LSM12 homolog (S. cerevisiae) |
|
affects expression |
EXP |
11 |
102,024,803 |
102,046,570 |
RGD:6480464 |
CTD |
| G |
Lsmd1 |
LSM domain containing 1 |
|
multiple interactions |
ISO |
11 |
69,209,293 |
69,210,173 |
RGD:6480464 |
CTD |
| G |
Lss |
lanosterol synthase |
|
affects expression |
EXP |
10 |
75,994,372 |
76,016,679 |
RGD:6480464 |
CTD |
| G |
Ltb4r2 |
leukotriene B4 receptor 2 |
|
affects expression |
EXP |
14 |
56,380,761 |
56,381,843 |
RGD:6480464 |
CTD |
| G |
Ltv1 |
LTV1 homolog (S. cerevisiae) |
|
affects expression |
EXP |
10 |
12,898,443 |
12,912,943 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
increases expression |
ISO |
10 |
97,028,135 |
97,035,337 |
RGD:6480464 |
CTD |
| G |
Luzp1 |
leucine zipper protein 1 |
|
decreases expression |
EXP |
4 |
136,025,676 |
136,105,233 |
RGD:6480464 |
CTD |
| G |
Ly6a |
lymphocyte antigen 6 complex, locus A |
|
affects expression |
EXP |
15 |
74,825,307 |
74,828,318 |
RGD:6480464 |
CTD |
| G |
Ly6d |
lymphocyte antigen 6 complex, locus D |
|
affects expression |
EXP |
15 |
74,592,486 |
74,593,997 |
RGD:6480464 |
CTD |
| G |
Ly6g6d |
lymphocyte antigen 6 complex, locus G6D |
|
affects expression |
EXP |
17 |
35,208,293 |
35,211,409 |
RGD:6480464 |
CTD |
| G |
Ly75 |
lymphocyte antigen 75 |
|
increases expression |
ISO |
2 |
60,131,817 |
60,221,288 |
RGD:6480464 |
CTD |
| G |
Ly86 |
lymphocyte antigen 86 |
|
multiple interactions |
ISO |
13 |
37,437,214 |
37,510,905 |
RGD:6480464 |
CTD |
| G |
Ly86 |
lymphocyte antigen 86 |
|
affects expression |
EXP |
13 |
37,437,214 |
37,510,905 |
RGD:6480464 |
CTD |
| G |
Lynx1 |
Ly6/neurotoxin 1 |
|
increases expression |
EXP |
15 |
74,578,286 |
74,583,409 |
RGD:6480464 |
CTD |
| G |
Lypd5 |
Ly6/Plaur domain containing 5 |
|
affects expression |
EXP |
7 |
25,134,243 |
25,138,852 |
RGD:6480464 |
CTD |
| G |
Lyplal1 |
lysophospholipase-like 1 |
|
affects expression |
EXP |
1 |
187,911,611 |
187,941,189 |
RGD:6480464 |
CTD |
| G |
Lyz2 |
lysozyme 2 |
|
affects expression |
EXP |
10 |
116,714,597 |
116,719,328 |
RGD:6480464 |
CTD |
| G |
Macrod1 |
MACRO domain containing 1 |
|
affects expression |
EXP |
19 |
7,131,258 |
7,272,552 |
RGD:6480464 |
CTD |
| G |
Mad2l1bp |
MAD2L1 binding protein |
|
affects expression |
EXP |
17 |
46,284,334 |
46,290,500 |
RGD:6480464 |
CTD |
| G |
Mad2l2 |
MAD2 mitotic arrest deficient-like 2 |
|
increases expression |
EXP |
4 |
147,514,599 |
147,519,805 |
RGD:6480464 |
CTD |
| G |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) |
|
affects expression |
EXP |
2 |
160,189,413 |
160,192,801 |
RGD:6480464 |
CTD |
| G |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
|
affects expression |
EXP |
11 |
120,489,662 |
120,494,861 |
RGD:6480464 |
CTD |
| G |
Magea10 |
melanoma antigen family A, 10 |
|
affects expression |
EXP |
X |
69,627,209 |
69,632,197 |
RGD:6480464 |
CTD |
| G |
Maged2 |
melanoma antigen, family D, 2 |
|
affects expression |
EXP |
X |
147,240,964 |
147,248,825 |
RGD:6480464 |
CTD |
| G |
Magee1 |
melanoma antigen, family E, 1 |
|
increases expression |
EXP |
X |
102,315,735 |
102,319,251 |
RGD:6480464 |
CTD |
| G |
Magt1 |
magnesium transporter 1 |
|
affects expression |
EXP |
X |
103,163,423 |
103,207,238 |
RGD:6480464 |
CTD |
| G |
Mal2 |
mal, T cell differentiation protein 2 |
|
affects expression |
EXP |
15 |
54,402,921 |
54,434,401 |
RGD:6480464 |
CTD |
| G |
Man2a1 |
mannosidase 2, alpha 1 |
|
affects expression |
EXP |
17 |
64,950,989 |
65,104,450 |
RGD:6480464 |
CTD |
| G |
Meaf6 |
MYST/Esa1-associated factor 6 |
|
decreases expression |
EXP |
4 |
124,762,391 |
124,787,133 |
RGD:6480464 |
CTD |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
multiple interactions |
EXP |
X |
71,272,160 |
71,330,975 |
RGD:6480464 |
CTD |
| G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
|
affects expression |
EXP |
4 |
131,399,386 |
131,423,702 |
RGD:6480464 |
CTD |
| G |
Med11 |
mediator of RNA polymerase II transcription, subunit 11 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
11 |
70,265,433 |
70,267,229 |
RGD:6480464 |
CTD |
| G |
Med12l |
mediator of RNA polymerase II transcription, subunit 12 homolog (yeast)-like |
|
affects expression |
EXP |
3 |
58,810,900 |
59,122,338 |
RGD:6480464 |
CTD |
| G |
Med14 |
mediator complex subunit 14 |
|
affects expression |
EXP |
X |
12,252,497 |
12,339,099 |
RGD:6480464 |
CTD |
| G |
Med18 |
mediator of RNA polymerase II transcription, subunit 18 homolog (yeast) |
|
affects expression |
EXP |
4 |
132,014,644 |
132,019,836 |
RGD:6480464 |
CTD |
| G |
Med24 |
mediator complex subunit 24 |
|
affects expression |
EXP |
11 |
98,565,905 |
98,590,749 |
RGD:6480464 |
CTD |
| G |
Med8 |
mediator of RNA polymerase II transcription, subunit 8 homolog (yeast) |
|
multiple interactions |
ISO |
4 |
118,081,942 |
118,088,387 |
RGD:6480464 |
CTD |
| G |
Mef2c |
myocyte enhancer factor 2C |
|
increases expression |
ISO |
13 |
83,643,033 |
83,806,684 |
RGD:6480464 |
CTD |
| G |
Mef2d |
myocyte enhancer factor 2D |
|
affects expression |
EXP |
3 |
87,946,317 |
87,973,089 |
RGD:6480464 |
CTD |
| G |
Megf11 |
multiple EGF-like-domains 11 |
|
affects expression |
EXP |
9 |
64,233,433 |
64,557,012 |
RGD:6480464 |
CTD |
| G |
Meig1 |
meiosis expressed gene 1 |
|
increases expression |
EXP |
2 |
3,326,315 |
3,339,920 |
RGD:6480464 |
CTD |
| G |
Men1 |
multiple endocrine neoplasia 1 |
|
affects expression |
EXP |
19 |
6,334,979 |
6,340,894 |
RGD:6480464 |
CTD |
| G |
Men1 |
multiple endocrine neoplasia 1 |
|
increases expression |
EXP |
19 |
6,334,979 |
6,340,894 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
affects expression |
EXP |
12 |
37,835,133 |
37,906,115 |
RGD:6480464 |
CTD |
| G |
Mepce |
methylphosphate capping enzyme |
|
decreases expression |
ISO |
5 |
138,223,134 |
138,227,929 |
RGD:6480464 |
CTD |
| G |
Mertk |
c-mer proto-oncogene tyrosine kinase |
|
increases expression |
ISO |
2 |
128,524,733 |
128,627,923 |
RGD:6480464 |
CTD |
| G |
Mesdc2 |
mesoderm development candidate 2 |
|
affects expression |
EXP |
7 |
91,040,510 |
91,050,042 |
RGD:6480464 |
CTD |
| G |
Mesp2 |
mesoderm posterior 2 |
|
affects expression |
EXP |
7 |
86,955,613 |
86,958,317 |
RGD:6480464 |
CTD |
| G |
Metrn |
meteorin, glial cell differentiation regulator |
|
increases expression |
ISO |
17 |
25,931,516 |
25,933,990 |
RGD:6480464 |
CTD |
| G |
Metrnl |
meteorin, glial cell differentiation regulator-like |
|
affects expression |
EXP |
11 |
121,563,741 |
121,578,703 |
RGD:6480464 |
CTD |
| G |
Mettl21a |
methyltransferase like 21A |
|
decreases expression |
EXP |
1 |
64,653,054 |
64,663,742 |
RGD:6480464 |
CTD |
| G |
Mettl3 |
methyltransferase like 3 |
|
multiple interactions |
ISO |
14 |
52,914,516 |
52,924,799 |
RGD:6480464 |
CTD |
| G |
Mettl6 |
methyltransferase like 6 |
|
multiple interactions |
ISO |
14 |
32,291,984 |
32,308,163 |
RGD:6480464 |
CTD |
| G |
Mettl6 |
methyltransferase like 6 |
|
affects expression |
EXP |
14 |
32,291,984 |
32,308,163 |
RGD:6480464 |
CTD |
| G |
Mettl7a2 |
methyltransferase like 7A2 |
|
affects expression |
EXP |
15 |
100,183,631 |
100,192,250 |
RGD:6480464 |
CTD |
| G |
Mettl7b |
methyltransferase like 7B |
|
affects expression |
EXP |
10 |
128,395,333 |
128,398,044 |
RGD:6480464 |
CTD |
| G |
Mex3a |
mex3 homolog A (C. elegans) |
|
decreases expression |
ISO |
3 |
88,339,970 |
88,345,302 |
RGD:6480464 |
CTD |
| G |
Mfap3l |
microfibrillar-associated protein 3-like |
|
affects expression |
EXP |
8 |
63,111,657 |
63,155,528 |
RGD:6480464 |
CTD |
| G |
Mfap4 |
microfibrillar-associated protein 4 |
|
decreases expression |
ISO |
11 |
61,298,946 |
61,302,206 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
affects expression |
EXP |
7 |
86,278,654 |
86,293,946 |
RGD:6480464 |
CTD |
| G |
Mfi2 |
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
|
increases expression |
ISO |
16 |
31,878,896 |
31,899,106 |
RGD:6480464 |
CTD |
| G |
Mfn1 |
mitofusin 1 |
|
affects expression |
EXP |
3 |
32,428,404 |
32,478,147 |
RGD:6480464 |
CTD |
| G |
Mfsd1 |
major facilitator superfamily domain containing 1 |
|
increases expression |
ISO |
3 |
67,386,690 |
67,408,153 |
RGD:6480464 |
CTD |
| G |
Mfsd10 |
major facilitator superfamily domain containing 10 |
|
affects expression |
EXP |
5 |
34,976,296 |
34,979,763 |
RGD:6480464 |
CTD |
| G |
Mfsd2a |
major facilitator superfamily domain containing 2A |
|
affects expression |
EXP |
4 |
122,624,093 |
122,638,431 |
RGD:6480464 |
CTD |
| G |
Mfsd7b |
major facilitator superfamily domain containing 7B |
|
affects expression |
EXP |
1 |
192,829,711 |
192,850,069 |
RGD:6480464 |
CTD |
| G |
Mfsd9 |
major facilitator superfamily domain containing 9 |
|
affects expression |
EXP |
1 |
40,828,885 |
40,847,502 |
RGD:6480464 |
CTD |
| G |
Mgat1 |
mannoside acetylglucosaminyltransferase 1 |
|
multiple interactions |
ISO |
11 |
49,057,693 |
49,076,529 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannoside acetylglucosaminyltransferase 2 |
|
affects expression |
EXP |
12 |
70,285,145 |
70,287,760 |
RGD:6480464 |
CTD |
| G |
Mgea5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
decreases expression |
EXP |
19 |
45,824,749 |
45,857,781 |
RGD:6480464 |
CTD |
| G |
Mgea5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
multiple interactions |
ISO |
19 |
45,824,749 |
45,857,781 |
RGD:6480464 |
CTD |
| G |
Mgll |
monoglyceride lipase |
|
affects expression |
EXP |
6 |
88,674,406 |
88,778,354 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects expression |
EXP |
7 |
144,086,294 |
144,319,871 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
multiple interactions |
ISO |
6 |
136,820,956 |
136,824,326 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
affects expression |
EXP |
1 |
169,302,515 |
169,323,928 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
increases expression |
EXP |
1 |
169,302,515 |
169,323,928 |
RGD:6480464 |
CTD |
| G |
Mia3 |
melanoma inhibitory activity 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mia3 |
melanoma inhibitory activity 3 |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Mib2 |
mindbomb homolog 2 (Drosophila) |
|
increases expression |
EXP |
4 |
155,028,579 |
155,043,336 |
RGD:6480464 |
CTD |
| G |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
|
affects expression |
EXP |
6 |
120,957,258 |
121,031,627 |
RGD:6480464 |
CTD |
| G |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
|
multiple interactions |
ISO |
6 |
120,957,258 |
121,031,627 |
RGD:6480464 |
CTD |
| G |
Micall1 |
microtubule associated monooxygenase, calponin and LIM domain containing -like 1 |
|
increases expression |
EXP |
15 |
78,939,413 |
78,967,330 |
RGD:6480464 |
CTD |
| G |
Micu1 |
mitochondrial calcium uptake 1 |
|
increases expression |
ISO |
10 |
59,165,383 |
59,326,871 |
RGD:6480464 |
CTD |
| G |
Micu1 |
mitochondrial calcium uptake 1 |
|
increases expression |
EXP |
10 |
59,165,383 |
59,326,871 |
RGD:6480464 |
CTD |
| G |
Mid1ip1 |
Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) |
|
affects expression |
EXP |
X |
10,294,491 |
10,296,828 |
RGD:6480464 |
CTD |
| G |
Mill2 |
MHC I like leukocyte 2 |
|
increases expression |
ISO |
7 |
19,425,315 |
19,444,002 |
RGD:6480464 |
CTD |
| G |
Mipep |
mitochondrial intermediate peptidase |
|
affects expression |
EXP |
14 |
61,403,403 |
61,522,450 |
RGD:6480464 |
CTD |
| G |
Mis12 |
MIS12 homolog (yeast) |
|
multiple interactions |
ISO |
11 |
70,833,113 |
70,840,636 |
RGD:6480464 |
CTD |
| G |
Mitd1 |
MIT, microtubule interacting and transport, domain containing 1 |
|
affects expression |
EXP |
1 |
37,935,735 |
37,947,256 |
RGD:6480464 |
CTD |
| G |
Mrpl50 |
mitochondrial ribosomal protein L50 |
|
affects expression |
EXP |
4 |
49,525,469 |
49,533,955 |
RGD:6480464 |
CTD |
| G |
Mrpl53 |
mitochondrial ribosomal protein L53 |
|
multiple interactions |
ISO |
6 |
83,059,102 |
83,059,926 |
RGD:6480464 |
CTD |
| G |
Mrps12 |
mitochondrial ribosomal protein S12 |
|
multiple interactions |
ISO |
7 |
29,524,660 |
29,526,800 |
RGD:6480464 |
CTD |
| G |
Mrps18a |
mitochondrial ribosomal protein S18A |
|
multiple interactions |
ISO |
17 |
46,247,953 |
46,265,857 |
RGD:6480464 |
CTD |
| G |
Mrps18b |
mitochondrial ribosomal protein S18B |
|
affects expression |
EXP |
17 |
36,047,330 |
36,053,314 |
RGD:6480464 |
CTD |
| G |
Mrps2 |
mitochondrial ribosomal protein S2 |
|
decreases expression |
EXP |
2 |
28,323,586 |
28,326,697 |
RGD:6480464 |
CTD |
| G |
Mrps24 |
mitochondrial ribosomal protein S24 |
|
multiple interactions |
ISO |
11 |
5,603,986 |
5,607,702 |
RGD:6480464 |
CTD |
| G |
Mrps24 |
mitochondrial ribosomal protein S24 |
|
affects expression |
EXP |
11 |
5,603,986 |
5,607,702 |
RGD:6480464 |
CTD |
| G |
Mrps30 |
mitochondrial ribosomal protein S30 |
|
decreases expression |
EXP |
13 |
119,168,917 |
119,176,059 |
RGD:6480464 |
CTD |
| G |
Mrps5 |
mitochondrial ribosomal protein S5 |
|
multiple interactions |
ISO |
2 |
127,413,162 |
127,429,722 |
RGD:6480464 |
CTD |
| G |
Mrrf |
mitochondrial ribosome recycling factor |
|
multiple interactions |
ISO |
2 |
35,991,918 |
36,045,804 |
RGD:6480464 |
CTD |
| G |
Mrrf |
mitochondrial ribosome recycling factor |
|
affects expression |
EXP |
2 |
35,991,918 |
36,045,804 |
RGD:6480464 |
CTD |
| G |
Ms4a1 |
membrane-spanning 4-domains, subfamily A, member 1 |
|
affects expression |
EXP |
19 |
11,325,093 |
11,340,641 |
RGD:6480464 |
CTD |
| G |
Ms4a2 |
membrane-spanning 4-domains, subfamily A, member 2 |
|
affects expression |
EXP |
19 |
11,691,683 |
11,698,133 |
RGD:6480464 |
CTD |
| G |
Ms4a5 |
membrane-spanning 4-domains, subfamily A, member 5 |
|
affects expression |
EXP |
19 |
11,348,356 |
11,358,303 |
RGD:6480464 |
CTD |
| G |
Msgn1 |
mesogenin 1 |
|
affects expression |
EXP |
12 |
11,215,188 |
11,215,754 |
RGD:6480464 |
CTD |
| G |
Msh3 |
mutS homolog 3 (E. coli) |
|
affects expression |
EXP |
13 |
92,981,836 |
93,124,958 |
RGD:6480464 |
CTD |
| G |
Msh5 |
mutS homolog 5 (E. coli) |
|
affects expression |
EXP |
17 |
35,165,550 |
35,183,668 |
RGD:6480464 |
CTD |
| G |
Msi2 |
musashi RNA-binding protein 2 |
|
affects expression |
EXP |
11 |
88,152,884 |
88,403,661 |
RGD:6480464 |
CTD |
| G |
Msl1 |
male-specific lethal 1 homolog (Drosophila) |
|
affects expression |
EXP |
11 |
98,657,083 |
98,669,173 |
RGD:6480464 |
CTD |
| G |
Msl1 |
male-specific lethal 1 homolog (Drosophila) |
|
decreases expression |
EXP |
11 |
98,657,083 |
98,669,173 |
RGD:6480464 |
CTD |
| G |
Msl2 |
male-specific lethal 2 homolog (Drosophila) |
|
decreases expression |
EXP |
9 |
101,002,900 |
101,007,130 |
RGD:6480464 |
CTD |
| G |
Msln |
mesothelin |
|
affects expression |
EXP |
17 |
25,885,558 |
25,891,272 |
RGD:6480464 |
CTD |
| G |
Msrb2 |
methionine sulfoxide reductase B2 |
|
decreases expression |
EXP |
2 |
19,293,263 |
19,316,597 |
RGD:6480464 |
CTD |
| G |
Mss51 |
MSS51 mitochondrial translational activator |
|
affects expression |
EXP |
14 |
21,302,086 |
21,316,123 |
RGD:6480464 |
CTD |
| G |
Mvb12a |
multivesicular body subunit 12A |
|
affects expression |
EXP |
8 |
74,066,829 |
74,071,925 |
RGD:6480464 |
CTD |
| G |
Mvb12b |
multivesicular body subunit 12B |
|
decreases expression |
ISO |
2 |
33,585,476 |
33,743,466 |
RGD:6480464 |
CTD |
| G |
Mvb12b |
multivesicular body subunit 12B |
|
affects expression |
EXP |
2 |
33,585,476 |
33,743,466 |
RGD:6480464 |
CTD |
| G |
Myzap |
myocardial zonula adherens protein |
|
multiple interactions |
ISO |
9 |
71,352,154 |
71,440,167 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
affects expression |
EXP |
18 |
33,596,673 |
33,623,683 |
RGD:6480464 |
CTD |
| G |
Pced1b |
PC-esterase domain containing 1B |
|
affects expression |
EXP |
15 |
97,077,538 |
97,216,124 |
RGD:6480464 |
CTD |
| G |
Pced1b |
PC-esterase domain containing 1B |
|
decreases expression |
EXP |
15 |
97,077,538 |
97,216,124 |
RGD:6480464 |
CTD |
| G |
Sc4mol |
sterol-C4-methyl oxidase-like |
|
affects expression |
EXP |
8 |
67,196,942 |
67,212,375 |
RGD:6480464 |
CTD |
| G |
Tango2 |
transport and golgi organization 2 |
|
affects expression |
EXP |
16 |
18,300,918 |
18,344,025 |
RGD:6480464 |
CTD |
| G |
Tango2 |
transport and golgi organization 2 |
|
increases expression |
EXP |
16 |
18,300,918 |
18,344,025 |
RGD:6480464 |
CTD |
| G |
Tmem254a |
transmembrane protein 254a |
|
affects expression |
EXP |
14 |
26,742,784 |
26,747,158 |
RGD:6480464 |
CTD |
| G |
Tmem254a |
transmembrane protein 254a |
|
decreases expression |
EXP |
14 |
26,742,784 |
26,747,158 |
RGD:6480464 |
CTD |
| G |
Vimp |
VCP-interacting membrane protein |
|
affects expression |
EXP |
7 |
73,224,535 |
73,234,291 |
RGD:6480464 |
CTD |
Term paths to the root
|